<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="ppub"/></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS140197</article-id><article-id pub-id-type="doi">10.1101/2021.11.22.469642</article-id><article-id pub-id-type="archive">PPR425031</article-id><article-version-alternatives><article-version article-version-type="status">preprint</article-version><article-version article-version-type="number">2</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group><subj-group subj-group-type="europepmc-category"><subject>Covid-19</subject></subj-group></article-categories><title-group><article-title>Unambiguous detection of SARS-CoV-2 subgenomic mRNAs with single cell RNA sequencing</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Cohen</surname><given-names>Phillip</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>DeGrace</surname><given-names>Emma J</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Danziger</surname><given-names>Oded</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Patel</surname><given-names>Roosheel S</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Barrall</surname><given-names>Erika A</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Bobrowski</surname><given-names>Tesia</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Kehrer</surname><given-names>Thomas</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Cupic</surname><given-names>Anastasija</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Miorin</surname><given-names>Lisa</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>García-Sastre</surname><given-names>Adolfo</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Rosenberg</surname><given-names>Brad R</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="corresp" rid="CR1">#</xref></contrib><aff id="A1"><label>1</label>Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10035</aff></contrib-group><author-notes><corresp id="CR1">
<label>#</label>Address correspondence to Brad R Rosenberg, <email>brad.rosenberg@mssm.edu</email>
</corresp></author-notes><pub-date pub-type="nihms-submitted"><day>27</day><month>11</month><year>2021</year></pub-date><pub-date pub-type="preprint"><day>24</day><month>11</month><year>2021</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND 4.0 International license</ext-link>.</license-p></license></permissions><abstract><p id="P1">Single cell RNA sequencing (scRNA-Seq) studies have provided critical insight into the pathogenesis of Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2), the causative agent of COronaVIrus Disease 2019 (COVID-19). scRNA-Seq workflows are generally designed for the detection and quantification of eukaryotic host mRNAs and not viral RNAs. Here, we compare different scRNA-Seq methods for their ability to quantify and detect SARS-CoV-2 RNAs with a focus on subgenomic mRNAs (sgmRNAs). We present a data processing strategy, single cell CoronaVirus sequencing (scCoVseq), which quantifies reads unambiguously assigned to sgmRNAs or genomic RNA (gRNA). Compared to standard 10X Genomics Chromium Next GEM Single Cell 3′ (10X 3′) and Chromium Next GEM Single Cell V(D)J (10X 5′) sequencing, we find that 10X 5′ with an extended read 1 (R1) sequencing strategy maximizes the detection of sgmRNAs by increasing the number of unambiguous reads spanning leader-sgmRNA junction sites. Using this method, we show that viral gene expression is highly correlated across cells suggesting a relatively consistent proportion of viral sgmRNA production throughout infection. Our method allows for quantification of coronavirus sgmRNA expression at single-cell resolution, and thereby supports high resolution studies of the dynamics of coronavirus RNA synthesis.</p></abstract></article-meta></front><body><sec id="S1" sec-type="intro"><title>Introduction</title><p id="P2">Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) is the causative agent of COronaVIrus Disease-2019 (COVID-19), which as of January 2023 has caused over 663 million cases and over 6.7 million deaths globally(<xref ref-type="bibr" rid="R1">1</xref>, <xref ref-type="bibr" rid="R2">2</xref>). Global efforts to understand the pathogenesis of SARS-CoV-2 infection have led to the development of vaccines and antiviral drugs, which have significantly reduced morbidity and mortality(<xref ref-type="bibr" rid="R3">3</xref>). “Omics” methods have been instrumental in studying SARS-CoV-2 in part because they have generated large amounts of data regarding host-viral interactions at unprecedented speed(<xref ref-type="bibr" rid="R4">4</xref>–<xref ref-type="bibr" rid="R15">15</xref>). Single-cell RNA sequencing (scRNA-Seq) studies in particular have been used to study multiple aspects of SARS-CoV-2 infection including but not limited to: viral tropism(<xref ref-type="bibr" rid="R16">16</xref>–<xref ref-type="bibr" rid="R22">22</xref>), peripheral immune changes(<xref ref-type="bibr" rid="R23">23</xref>–<xref ref-type="bibr" rid="R33">33</xref>), transcriptional changes induced by infection(<xref ref-type="bibr" rid="R34">34</xref>, <xref ref-type="bibr" rid="R35">35</xref>), and to develop cell atlases of COVID-19 pathology(<xref ref-type="bibr" rid="R23">23</xref>, <xref ref-type="bibr" rid="R24">24</xref>, <xref ref-type="bibr" rid="R36">36</xref>, <xref ref-type="bibr" rid="R37">37</xref>). Of note, most scRNA-Seq workflows have been developed and optimized for studies of eukaryotic transcription but not viral, specifically SARS-CoV-2, transcription. The performance of different scRNA-Seq methods to detect and quantify viral RNAs may impact the analysis and interpretation of such studies.</p><p id="P3">SARS-CoV-2 is a betacoronavirus with a 29 kB positive-sense, single stranded RNA genome(<xref ref-type="bibr" rid="R38">38</xref>, <xref ref-type="bibr" rid="R39">39</xref>). SARS-CoV-2 generates genomic RNA (gRNA), subgenomic mRNAs (sgmRNAs), and negative-sense antigenomic RNA during active infection(<xref ref-type="bibr" rid="R40">40</xref>, <xref ref-type="bibr" rid="R41">41</xref>). Both gRNA and sgmRNAs are polyadenylated, which enables detection by scRNA-Seq protocols that rely on poly-T primed reverse transcription(<xref ref-type="bibr" rid="R39">39</xref>–<xref ref-type="bibr" rid="R41">41</xref>). Translation of gRNA results in the production of one of two polyproteins, pp1a and pp1ab, which are subsequently cleaved into an array of non-structural proteins involved in pathogenesis and replication(<xref ref-type="bibr" rid="R39">39</xref>, <xref ref-type="bibr" rid="R41">41</xref>). Translation of sgmRNAs generates structural and accessory viral proteins critical for virion production and pathogenesis(<xref ref-type="bibr" rid="R39">39</xref>, <xref ref-type="bibr" rid="R41">41</xref>). Specific detection of sgmRNAs is therefore necessary for the analysis of viral gene expression dynamics within and across cells and viruses.</p><p id="P4">sgmRNAs are generated by discontinuous transcription events during negative strand synthesis(<xref ref-type="bibr" rid="R40">40</xref>). Transcription Regulatory Sequences (TRS), present in the 5′ leader sequence of the virus (TRS-L) and upstream of each ORF body (TRS-B), regulate this process(<xref ref-type="bibr" rid="R40">40</xref>). Template switching of the viral polymerase from a TRS-B to a TRS-L generates sgmRNAs with the 5′ leader sequence fused to the sgmRNA ORF body (<xref ref-type="fig" rid="F1">Figure 1A</xref>)(<xref ref-type="bibr" rid="R40">40</xref>). These “nested” sgmRNAs share the viral ORF sequence downstream of the junction site in addition to a common leader sequence upstream of the junction site(<xref ref-type="bibr" rid="R40">40</xref>). This redundancy poses a challenge for standard scRNA-Seq data processing pipelines because reads mapping to redundant sgmRNA sequences are categorized as “ambiguous” and typically excluded from quantification. This problem has been addressed in bulk RNA-Seq by quantifying SARS-CoV-2 reads spanning leader-ORF junctions, which unambiguously identify sgmRNAs(<xref ref-type="bibr" rid="R12">12</xref>, <xref ref-type="bibr" rid="R15">15</xref>). However, many scRNA-Seq methods do not sequence this region of sgmRNAs at significant coverage due to differences in library format and configuration of sequencing reads.</p><p id="P5">We hypothesized that both experimental (i.e. scRNA-Seq library construction and sequencing strategies) and data processing decisions influence the ability to detect, resolve, and quantify SARS-CoV-2 RNA species with scRNA-Seq. We developed a data processing workflow, single cell coronavirus sequencing (scCoVseq), to quantify only unambiguous SARS-CoV-2 sgmRNA reads in scRNA-Seq data. We found that SARS-CoV-2 RNA detection differed by 10X Genomics Chromium scRNA-Seq library construction methods, due in part to ambiguity of the library fragments generated by each method. We show that 10X Chromium Next GEM Single Cell V(D)J (10X 5′) scRNA-Seq with an extended read 1 (R1) sequencing strategy maximized unambiguous SARS-CoV-2 reads and thereby increased detection of SARS-CoV-2 RNAs. Our method yielded similar sgmRNA quantities in aggregated scRNA-Seq data as detected with previously published bulk RNA-Seq methods(<xref ref-type="bibr" rid="R42">42</xref>). Using this method, we show that viral gene expression is highly correlated across infected cells, which may suggest that the relative proportion of viral sgmRNA expression is maintained throughout infection.</p></sec><sec id="S2" sec-type="materials | methods"><title>Materials and Methods</title><sec id="S3"><title>Cell lines and Viral Infection</title><p id="P6">Vero-E6 cells (ATCC, CRL-1586) were maintained in Dulbecco’s Modified Eagle Medium (DMEM, Corning) supplemented with 10% fetal-bovine serum (FBS) and 1% Penicillin Streptomycin (PSN, Fisher scientific), and routinely cultured at 37° C with 5% CO<sub>2</sub>. A549- ACE2 (previously described in (<xref ref-type="bibr" rid="R43">43</xref>, <xref ref-type="bibr" rid="R44">44</xref>) were maintained in Dulbecco’s modified Eagle’s medium (Corning) supplemented with 10% fetal bovine serum (Peak Serum) and penicillin/streptomycin (Corning) at 37 °C and 5% CO2. All cell lines used in this study were regularly screened for Mycoplasma contamination with the MycoAlert Detection Kit (Lonza).</p><p id="P7">All SARS-CoV-2 propagations and experiments were performed in a Biosafety Level 3 facility in compliance with institutional protocols and federal guidelines. For experiments involving Vero E6 cells, SARS-CoV-2 (isolate USA-WA1/2020, BEI resource NR-52281) and control media (mock infected) stocks were grown by inoculating a confluent T175 flask of Vero-E6 cells (passage 2). Mock and SARS-CoV-2 infected cultures were maintained in reduced serum DMEM (2% FBS) for 72 hours, after which culture media was collected and filtered by centrifugation (8000 x g, 15 minutes) using an Amicon Ultra-15 filter unit with a 100KDa cutoff filter (Millipore # UFC910024). Concentrated stocks in reduced-serum media (2% FBS), supplemented with 50mM HEPES buffer (Gibco) were stored at -80°C. Viral titers were determined by plaque assay as previously described(<xref ref-type="bibr" rid="R43">43</xref>).</p><p id="P8">For experiments involving A549-ACE2 cells, a recombinant SARS-CoV-2 (rSARS-CoV-2) virus, rSARS-CoV-2 ORF6 M58R, was used as described elsewhere(<xref ref-type="bibr" rid="R45">45</xref>). All viral stocks were grown in Vero E6 cells as previously described and validated by genome sequencing (<xref ref-type="bibr" rid="R35">35</xref>). Sequencing was either performed using the MinION sequencer (Oxford Nanopore Technologies) or with the Nextera XT DNA Sample Preparation kit (Illumina) as described elsewhere (<xref ref-type="bibr" rid="R46">46</xref>, <xref ref-type="bibr" rid="R47">47</xref>).</p></sec><sec id="S4"><title>scRNA-Seq</title><p id="P9">For scRNA-Seq experiments with Vero-E6 cells, cultures in 6 well plates were infected with SARS-CoV-2 at a MOI of 0.1, or with an equivalent volume of control media, in reduced-serum media (2% FBS) for 24 hours. To prepare cells for scRNA-Seq, mock and SARS-CoV-2 infected cultures were washed with calcium/magnesium-free PBS and disassociated using TrypLE (Gibco, 5 minutes at 37° C), after which samples were centrifuged (200 x g, 5 minutes), resuspended in calcium/magnesium-free PBS supplemented with 1% BSA, and counted. Mock and SARS-CoV-2 infected cell culture samples were filtered through a 40 μm FlowMi strainer (ScienceWare) and counted prior to loading on the 10X Genomics Chromium Controller according to manufacturer’s protocol. Mock and infected samples were loaded on separate lanes of a 10X Genomics Chromium Controller for either NextGEM Single Cell 3′ v3.1 (10X 3′), or NextGEM Single Cell V(D)J v1.1, (10X 5′).</p><p id="P10">scRNA-Seq gene expression libraries were prepared by 10X 3′ and 5′ library construction methods according to manufacturer’s guidelines. Final 10X 3′ mock and infected gene expression libraries and the 10X 5′ infected gene expression library were PCR amplified for 16 cycles while the 10X 5′ mock gene expression library was amplified for 14 cycles. 10X 3′ gene expression libraries were pooled and sequenced by short-read sequencing on an Illumina NextSeq 500 using a high output 150 cycle reaction kit according to manufacturers’ protocol with the following read lengths: read 1 28 nt; i7 index 8 nt; and read 2 130 nt. 10X 5′ gene expression libraries were also pooled and sequenced with 10X recommended read lengths (read 1 26 nt; i7 index 8 nt; and read 2 132 nt) or with extended R1 protocol (read 1 158 nt; i7 index 8 nt; no read 2).</p><p id="P11">For scRNA-Seq experiments with A549 cells, cultures were incubated with virus at an MOI of 2 in Dulbecco’s modified Eagle’s medium (Corning) supplemented with 2% fetal bovine serum (Peak Serum), 1% non-essential amino acids (Gibco), 1% HEPES (Gibco) and 1% penicillin/streptomycin (Corning) at 37 °C and 5% CO2. Cultures were incubated for 4 hours before supernatants were removed and replenished with fresh media. At 24 hours post-infection, cells were detached with TrypLE (Gibco), washed with PBS, and passed through a 70 μm filter. Finally, samples were processed using the Next GEM Single Cell Immune Profiling Assay (5’ RNA) single index kit (10X Genomics) according to the manufacturer’s instructions and as described previously, using 12 cycles of amplification during the cDNA amplification step (<xref ref-type="bibr" rid="R35">35</xref>). Sequencing was performed by the Icahn School of Medicine at Mount Sinai Genomics Core Facility using an Illumina NovaSeq with read lengths set to 200 bp for read 1, 8 bp for index 1, and 100 bp for read 2. Only read 1 was used for data denoted as 10X 5’ extended R1, and for analyses involving 10X 5’ data (i.e. not “extended”) R1 was truncated to 26 bases, the length required for cell barcode and UMI quantification, and read 2 was used without modification.</p></sec><sec id="S5"><title>scRNA-Seq Data Pre-Processing</title><sec id="S6"><title>Conversion of Illumina BCL files to fastq</title><p id="P12">Fastq files for standard sequencing of 3′ and 5′ gene expression libraries were generated using the mkfastq command in cellranger v.3.1.0 (10X Genomics). Fastq files for 5′ libraries sequenced with the extended R1 strategy were generated using bcl2fastq v2.20.0 (Illumina, Inc). Extended R1 fastqs were then separated into “pseudo R1” fastqs, containing the cell barcode and UMI, and “pseudo read 2 (R2)” fastqs, containing cDNA sequence, using a customized Python (v3.7.3) script (available at GitHub <italic>link pending</italic>) as follows.</p><p id="P13">The cell barcode and UMI are selected from the first 26 bp of R1. The subsequent 13 bp are derived from the template switch oligonucleotide and are ignored. The remaining nucleotides (and corresponding quality scores) are reverse complemented and stored as pseudo R2. The read header of the pseudo R2 fastqs are modified to reflect the format for standard R2 fastqs.</p></sec><sec id="S7"><title>Downsampling fastqs to control for sequencing depth</title><p id="P14">To control for differences in sequencing depth for each Vero E6 library, read depth per library was downsampled to approximately 50,000 reads per cell. To generate a whitelist of cell barcodes for downsampling while accounting for transcriptional shutdown in SARS-CoV-2 infected cells (<xref ref-type="bibr" rid="R35">35</xref>), we generated preliminary gene x cell matrices for our dataset using cellranger/3.1.0 count (10X Genomics, Inc) to quantify and align reads to a host reference (African Green Monkey, ChlSab1.1) combined with SARS-CoV-2 transcripts as annotated by NCBI SARS-CoV-2 reference (NC_045512.2) with modifications for USA/WA01 strain for each dataset. The resulting output was analyzed in R (v4.0.4) with Seurat (v4.0.1)(<xref ref-type="bibr" rid="R48">48</xref>–<xref ref-type="bibr" rid="R50">50</xref>) to filter out putative doublets and empty droplets according to total UMIs/cell, number of genes/cell, and percent of mitochondrial gene expression. After filtering, putative cell-containing cell barcodes were output to a whitelist per library. Based on the these whitelists, the initial fastq files were downsampled using seqtk (v1.2)(<xref ref-type="bibr" rid="R51">51</xref>) to a total read depth of 50,000 multiplied by the number of cells in the library.</p></sec><sec id="S8"><title>Preparation of empirically derived SARS-CoV-2 genome reference</title><p id="P15">Downsampled (for Vero E6 samples) and non-downsampled (for A549-ACE2 samples) fastq files were then mapped using cellranger count/3.1.0 (10X Genomics, Inc) to an empirically defined reference of SARS-CoV-2 sgmRNAs derived from previously reported SARS-CoV-2 (BetaCoV/Korea/KCDC03/2020) RNAs sequenced with long-read direct RNA Nanopore sequencing(<xref ref-type="bibr" rid="R12">12</xref>). These were downloaded from the UCSC Genome Browser Table Browser(<xref ref-type="bibr" rid="R52">52</xref>) after filtering for TRS-dependent transcripts and score &gt; 900 and exporting to GTF format. Transcripts for previously unknown ORFs were excluded from the annotation. An additional annotation for “genomic RNA” was included which covered the entire length of the SARS-CoV-2 genome. Aligning the BetaCoV/Korea/KCDC03/2020 genome with USA/WA-CDC-WA1/2020 genome showed that the USA/WA-CDC-WA1/2020 reference had an additional 21 3′ adenosine nucleotides annotated. To account for this in our reference, we extended any annotations from BetaCoV/Korea/KCDC03/2020 that ended at the 3′ end of the genome by an additional 21 bases. This SARS-CoV-2 reference was appended to the host ChlSab1.1 Ensembl reference for Vero E6 analyses or GRCh38 version 100 human reference for ACE2-A549 analyses.</p></sec></sec><sec id="S9"><title>scCoVseq</title><p id="P16">To unambiguously assign and quantify scRNA-Seq reads to SARS-CoV-2 RNAs, the cellranger output BAM was filtered for reads mapping to SARS-CoV-2 or ChlSab1.1 references using samtools (version 1.11)(<xref ref-type="bibr" rid="R53">53</xref>). SARS-CoV-2 aligned reads were then subset to likely genomic RNA reads or sgmRNA reads as follows. Genomic reads were defined as those containing no gaps in their alignment and mapping upstream of the start of the most 5′ sgmRNA, S. sgmRNA reads were defined as SARS-CoV-2 reads containing a gap and mapping in part to the 5′ leader sequence, defined as the 5′ proximal 80 nucleotides of the SARS-CoV-2 genome, and in part 3′ to the start of S. All other reads mapping to the SARS-CoV-2 genome were discarded. Reads passing these filtering steps were quantified with umi_tools (v1.0.0)(<xref ref-type="bibr" rid="R54">54</xref>). An R (v3.5.3) script using the Matrix (v1.2-18)(<xref ref-type="bibr" rid="R55">55</xref>) and readr (v1.3.1)(<xref ref-type="bibr" rid="R56">56</xref>) packages was used to convert this to a sparse matrix and save as an rds file. UMIs assigned to multiple genes were removed from the resulting matrix during downstream analysis.</p></sec><sec id="S10"><title>scRNA-Seq Data Analysis</title><sec id="S11"><title>Sashimi Plots</title><p id="P17">Reads from Vero E6 samples for 10X 3′, 10X 5′, and 10X 5′ extended R1 data that aligned to the SARS-CoV-2 reference by cellranger were subset from the cellranger output BAM file. Each BAM file was downsampled to approximately 1 × 10<sup>6</sup> reads to control for differences in sequencing depth across libraries. Sashimi plots were generated with ggsashimi (v1.0.0)(<xref ref-type="bibr" rid="R57">57</xref>).</p></sec><sec id="S12"><title>Classification of SARS-CoV-2 Infected Cells</title><p id="P18">scCoVseq-derived gene by cell matrices were loaded into R (v4.0.4) and analyzed with the Seurat (v4.0.1)(<xref ref-type="bibr" rid="R48">48</xref>–<xref ref-type="bibr" rid="R50">50</xref>) package. For each 10X method, mock and infected gene x cell matrices were merged with the Seurat merge command. To identify infected and bystander cells within SARS-CoV-2 treated cultures, euclidean distance between the z-scaled expression of SARS-CoV-2 sgmRNA UMIs per cell was clustered using k-medoids by the pam algorithm (k = 2) implemented in the cluster (v2.1.2) package(<xref ref-type="bibr" rid="R58">58</xref>). Output clusters were then compared for viral UMI expression per cell, and the cluster with more viral UMIs was classified as infected and the other as uninfected.</p></sec><sec id="S13"><title>Comparison of SARS-CoV-2 RNA UMIs per scRNA-Seq Method</title><p id="P19">To examine the distribution of SARS-CoV-2 UMIs per cell by scRNA-Seq method, the 25<sup>th</sup> percentile of total UMIs was quantified for all infected cells from each 10X method. Any cells with fewer UMIs than the minimum 25<sup>th</sup> percentile of all samples were discarded, and all cells were subsequently downsampled to this same number of total UMIs/cell using the Seurat SampleUMI command. Each dataset was randomly downsampled to the same number of infected cells to equalize for differences in cell numbers, and viral sgmRNA UMIs/cell were plotted by scRNA-Seq method.</p></sec><sec id="S14"><title>SARS-CoV-2 Read Distribution by scRNA-Seq Method</title><p id="P20">SARS-CoV-2 reads were defined as genomic or subgenomic using scCoVseq. Reads aligning to the SARS-CoV-2 reference that were excluded from scCoVseq were classified as ambiguous. The number of genomic, subgenomic, or ambiguous reads per million SARS-CoV-2 reads was calculated and plotted for each scRNA-Seq method.</p></sec><sec id="S15"><title>Differential Expression Analysis</title><p id="P21">To explore expression differences between infected, bystander, and mock cells, differential expression testing with edgeR (v3.32.1) was performed with modifications for scRNA-Seq as previously described(<xref ref-type="bibr" rid="R59">59</xref>, <xref ref-type="bibr" rid="R60">60</xref>). Viral genes were excluded from analysis, and only host genes expressed in at least 10% of cells were tested. To account for differences in RNA content of infected cells due to virus-induced transcriptional shutdown, all cells were downsampled to the 25<sup>th</sup> percentile of total UMIs of infected cells. Cells with fewer UMIs than the threshold were excluded from analysis. Differential gene expression was performed with edgeR using a generalized linear model quasi-likelihood F test adapted with a term for gene detection rate(<xref ref-type="bibr" rid="R59">59</xref>, <xref ref-type="bibr" rid="R60">60</xref>). Genes with an absolute log<sub>2</sub> fold change greater than or equal to 1 and false discovery rate less than 0.05 were considered significant. For KEGG enrichment analysis, pairwise tests between mock, bystander, and infected cells were performed. Differentially expressed genes with an absolute log<sub>2</sub> fold change greater than or equal to 1 and false discovery rate less than 0.05 were considered significant and subject to KEGG enrichment analysis using the KEGG annotations for African Green Monkey as implemented in the edgeR function kegga. <italic>Quantification of SARS-CoV-2 sgmRNA Junction Sites</italic>. We explored the ability of our extended R1 sequencing to detect SARS-CoV-2 sgmRNA junctions using STARsolo (version 2.7.8a)(<xref ref-type="bibr" rid="R61">61</xref>). Aligned reads were re-mapped to the empirical SARS-CoV-2 annotation described above and junction sites per cell were quantified. The resulting junction per cell matrix was plotted in R (v4.0.4).</p></sec></sec><sec id="S16"><title>Bulk RNA-Seq</title><sec id="S17"><title>Bulk RNA-Seq library preparation and sequencing</title><p id="P22">A549-ACE2 samples for bulk RNA sequencing were lysed in Trizol Reagent (Invitrogen) and total RNA was extracted using the miRNeasy mini kit (Qiagen) per the manufacturer’s instructions. DNAse treatment was performed on isolated RNA using the RNA Clean and Concentrator Kit (Zymo). Total RNA was examined for quantity and quality using the TapeStation (Agilent) and Quant-It RNA (ThermoFisher) systems. RNA samples with sufficient material (10 pg–10 ng) were passed to whole-transcriptome library preparation using the SMART-Seq v4 PLUS Kit (Takara Bio) following the manufacturer’s instructions. This library construction method was selected due to molecular similarities (e.g. 5′ template switch adaptor addition, full length cDNA amplification, etc.) to 10X Genomics Chromium scRNA-Seq library preparation. Briefly, total RNA inputs were normalized to 10ng in 10.5 µl going into preparation. 3′ ends of cDNA were then adenylated prior to ligation with adapters utilizing unique dual indices (96 UDIs) to barcode samples to allow for efficient pooling and high throughput sequencing. Libraries were enriched with PCR, with all samples undergoing 14 cycles of amplification prior to purification and pooling for sequencing. Bulk RNA sequencing was conducted on dual index libraries using a 300 cycle Mid Output kit on an Illumina NextSeq 500 with standard read configurations for R1, i7 index, i5 index, and R2:150, 8,8,150.</p></sec><sec id="S18"><title>Bulk RNA-Seq analysis</title><p id="P23">Raw BCL files were converted to fastq files using bcl2fastq/2.20.0 (Illumina, Inc). For quantification of SARS-CoV-2 sgRNA and gRNA expression, the periscope/0.1.2 package was used with the technology argument set to “illumina” (<xref ref-type="bibr" rid="R42">42</xref>). Finally, sgRNA reads per total mapped reads were calculated.</p></sec></sec><sec id="S19"><title>Flow Cytometry</title><p id="P24">Vero E6 cells were fixed with 4% paraformaldehyde at room temperature for a minimum of 24 hours, washed once with PBS and permeabilized with 1X perm-wash buffer (BD Biosciences) for 5 minutes. SARS-CoV nucleocapsid (N) antibody (clone 1C7C7) (kindly provided by Thomas Moran, Icahn School of Medicine at Mount Sinai, New York, NY), conjugated to AlexaFluor 647 was diluted 1:400 in perm-wash buffer, and added directly to samples. Samples were then incubated at room temperature for 40 minutes in the dark. After staining, samples were washed once with 1X perm-wash buffer, once with PBS, resuspended in FACS buffer (PBS supplemented with 1% FBS), and acquired on a Gallios flow cytometer (Beckman-Coulter). For all viral infections, analysis was performed with FlowJo software (v10.7.1, Becton Dickinson), excluding cell doublets and debris and gating according to mock infected populations.</p></sec><sec id="S20"><title>Immunofluorescence microscopy</title><p id="P25">Vero E6 were seeded in 6-well plates (Falcon) with one glass coverslip (Fisher Scientific) per well. After 24 hours post infection, cells were washed with PBS and fixed with 4% paraformaldehyde (Fisher Scientific) overnight. Fixed cells were permeabilized using 0.1% Triton-X (Fisher Scientific) in PBS and blocked with 4% bovine serum albumin (BSA, Fisher Scientific) in PBS. Blocked coverslips were incubated with SARS-N-1C7 (1:500 in 4% BSA PBS) overnight at 4C, washed three times with PBS, and incubated for 45 minutes with 1:500 AlexaFluor 488-conjugated anti-mouse (Invitrogen, 1:500 in 4% BSA PBS) plus DAPI (Thermo Fisher Scientific, 1:1000 in 4% BSA PBS) at room temperature. Coverslips were then stained with phalloidin (1:400 in PBS) for 1 hour at room temperature and washed again three times with PBS. Coverslips were mounted using Prolong Diamond (Life Technologies P36970). Confocal laser scanning microscopy was performed using a Leica SP5 DMI (ISMMS Microscopy CoRE and Advanced Bioimaging Center) with a 40X/1.25 oil objective. Images were collected at a resolution of 512 × 512 pixels in triplicate per slide. Images were processed and analyzed using LAS X and CellProfiler (v4) (<xref ref-type="bibr" rid="R62">62</xref>).</p></sec></sec><sec id="S21" sec-type="results"><title>Results</title><p id="P26">SARS-CoV-2 generates gRNA and sgmRNAs during infection, which are highly redundant in their sequences (<xref ref-type="fig" rid="F1">Figure 1A</xref>). In scRNA-Seq processing pipelines, reads mapping to redundant sequences are “assigned” to all genes containing that sequence and are typically excluded from quantification steps. We therefore identified read structures that could unambiguously identify gRNA or different species of sgmRNAs to allow for their specific quantification (<xref ref-type="fig" rid="F1">Figure 1B</xref>). Reads derived from gRNA should be contiguous and could map anywhere on the SARS-CoV-2 genome. Reads derived from sgmRNA could be either gapped or contiguous and could map to the 5′ leader and/or downstream of the start site of S, the most 5′ sgmRNA. Because contiguous reads mapping downstream of S could derive either from gRNA or sgmRNAs, they were excluded from quantification. We therefore defined gRNA reads as contiguous reads aligning upstream of regions contained in sgmRNAs. sgmRNA reads were defined as discontinuous reads spanning the leader region and regions used by sgmRNAs. Reads that did not match either of these formats could not be unambiguously assigned to gRNA or a sgmRNA and were therefore excluded from quantification (<xref ref-type="fig" rid="F1">Figure 1B</xref>). With this framework, we developed scCoVseq to quantify unambiguous genomic and subgenomic viral reads (<xref ref-type="fig" rid="F1">Figure 1C</xref>). Using scCoVseq, we compared the abilities of different scRNA-Seq methods to quantify SARS-CoV-2 RNAs.</p><p id="P27">In the widely available Chromium scRNA-Seq method developed by 10X Genomics, Inc, there are two formats for droplet-based scRNA-Seq: 10X 3′ and 10X 5′. 10X 3′ generates library fragments derived from the 3′ regions of polyadenylated RNAs within a cell (<xref ref-type="fig" rid="F2">Figure 2A</xref>). Because sgmRNAs share all viral sequence 3′ of the leader-body junction site, 10X 3′ library fragments derived from SARS-CoV-2 heavily cover the 3′ end of the viral genome and do not contain leader-ORF junctions (<xref ref-type="fig" rid="F2">Figure 2D</xref>). These reads are limited in their ability to differentiate gRNA from sgmRNA or distinguish different sgmRNA species. 10X 5′ generates library fragments from the 5′ termini of polyadenylated RNAs (<xref ref-type="fig" rid="F2">Figure 2B</xref>). These fragments are on average approximately 500 bp long (according to the manufacturer’s documentation) and would be expected to contain leader-ORF junctions of SARS-CoV-2 sgmRNAs. The transcript read (R2), however, derives from the 3′ end of these fragments and at the recommended read length of 91 bases is not long enough to consistently sequence into the leader-sgmRNA junction site (<xref ref-type="fig" rid="F2">Figure 2B</xref>). Reads from 10X 5′ can therefore contain some but not all junctions (<xref ref-type="fig" rid="F2">Figure 2E</xref>). We reasoned that we could use 10X 5′ library fragments to detect junction-spanning reads by sequencing from the 5′ end of the fragment. To do this we extended R1, which is normally used to sequence the cell barcode and UMI, to sequence into the leader-body junction site (<xref ref-type="fig" rid="F2">Figure 2C</xref>). Using 10X 5′ with extended R1, we were able to sequence more leader-sgmRNA junction sites and increase our ability to unambiguously quantify sgmRNAs (<xref ref-type="fig" rid="F2">Figure 2F</xref>). Indeed 10X 5′ extended R1 increased the number of leader-sgmRNA spanning reads over 10X 5′ and 10X 3′ (<xref ref-type="fig" rid="F2">Figure 2G</xref>).</p><p id="P28">Unexpectedly we observed a larger number of reads classified as gRNA in 10X 3′ compared to 10X 5′ or 10X 5′ with extended R1 (<xref ref-type="fig" rid="F2">Figure 2G</xref>), and there appears to be increased read coverage in ORF1a and ORF1ab in the 10X 3′ library as well (<xref ref-type="fig" rid="F2">Figure 2D</xref>). This phenomenon was also reported by Ravindra <italic>et al</italic> in their 10X 3′ libraries, who showed that these are non-canonical SARS-CoV-2 transcripts and not artifacts of the 10X 3′ library preparation (<xref ref-type="bibr" rid="R21">21</xref>). It is unclear at this time, however, why these transcripts may be better detected with 10X 3′ than 10X 5′.</p><p id="P29">When quantified with scCoVseq, we found that 10X 5′ extended R1 yields more UMIs for each sgmRNA per cell compared to 10X 5′ or 10X 3′ (<xref ref-type="fig" rid="F2">Figure 2H</xref>). Importantly, the average host gene expression per sample was significantly correlated across 5′ methods, suggesting that host gene measurements were minimally affected by 10X 5′ extended R1 (<xref ref-type="supplementary-material" rid="SD1">Supplemental Figure 1A-C</xref>). For select host genes, we observed higher detection in 10X 5′ than 10X 5′ extended R1 in Vero cell data. Interestingly, however, when analyzing data from human A549 cells, we did not see any notable differences in quantification of host genes between 10X 5′ and 10X 5′ extended R1 (<xref ref-type="supplementary-material" rid="SD1">Supplemental Figure 1D</xref>). These differences, which are apparent for a small subset of total genes, may be a consequence of incomplete annotation of the African Green Monkey transcriptome reference, as they are not apparent with human data mapped to the more thoroughly curated human reference. Furthermore, in all of these analyses, viral genes were shown to be detected at higher levels (in aggregate) with 10X 5′ extended R1 without impacting host gene quantification. Taken together, 10X 5′ libraries sequenced with extended R1 sequencing results in a greater number of unambiguous reads derived from sgmRNAs over 10X 3′ or 10X 5′, and consequently recovers more sgmRNA UMIs/cell without affecting host gene quantification.</p><p id="P30">We next explored the ability of scCoVseq to quantify sgmRNAs as compared to previously published methods. To do this, we aggregated (to “pseudobulk” profiles) scRNA-Seq data of ACE2-expressing A549 cells infected with recombinant SARS-CoV-2 (rSARS-CoV-2) ORF6 M58R, an attenuated mutant that allows for high MOI infection without excessive cell death (<xref ref-type="bibr" rid="R45">45</xref>). In parallel, triplicate bulk RNA-Seq libraries were prepared from these cultures and quantified with periscope, a previously published method to quantify SARS-CoV-2 sgmRNAs in bulk RNAseq data using partial alignments of viral reads to TRS and ORF sequence(<xref ref-type="bibr" rid="R42">42</xref>). We compared the detection of sgmRNAs in aggregated “pseudobulk” scRNA-Seq data to the mean expression values in the bulk RNA-Seq data. We further compared 10X 5′ and 10X 5′ extended R1 data as well as data from each quantified with either CellRanger or our scCoVseq method (<xref ref-type="fig" rid="F3">Figure 3</xref>). We found that either using 10X 5′ extended R1 sequencing or quantifying 10X 5′ with scCoVseq improved the correlation between aggregated scRNA-Seq data and bulk RNA-Seq data. The combination of 10X 5′ extended R1 and scCoVseq did not appear to improve further the correlation between scRNA-Seq and bulk RNA-Seq data. This analysis also showed that scRNA-Seq tends to detect higher levels of N and ORF6 sgmRNA and lower levels of ORF3a and M sgmRNA than bulk RNA-Seq. This may be due to differences in the properties of single cell as compared to bulk RNA-Seq library preparation or differences in the quantification of reads by the analysis pipelines used for each. Overall, these data suggests that 10X 5′ with extended R1 or scCoVseq improve the correlation of viral sgmRNA with bulk RNA-Seq quantification, but as described above, only the combination of both approaches maximizes the number of UMIs detected per sgmRNA per cell.</p><p id="P31">Next we sought to assess the relative expression of sgmRNAs during SARS-CoV-2 infection in single cells. We analyzed Vero E6 cells 24 hours post infection with SARS-CoV-2 at an MOI of 0.1 prepared with 10X 5′ extended R1 and analyzed with scCoVseq. We were able to quantify sgmRNAs and gRNA at single-cell resolution (<xref ref-type="fig" rid="F4">Figure 4A</xref>). We classified infected cells using a k-medoid clustering approach based on sgmRNA expression (<xref ref-type="fig" rid="F4">Figure 4B</xref>). We found that this classification method effectively separated cells with high levels of viral RNA from cells with low viral RNA (<xref ref-type="supplementary-material" rid="SD1">Supplemental Figure 2B</xref>) and detected a similar percentage of infected cells as detected using flow cytometry and immunofluorescence microscopy of the same cultures (<xref ref-type="supplementary-material" rid="SD1">Supplemental Figure 3C</xref>). We observed a progressive increase in all viral RNAs as total viral RNA UMI count increased in infected cells (<xref ref-type="fig" rid="F4">Figure 4C</xref>). We further found that viral gene expression was highly correlated across cells, suggesting that the relative proportions of viral gene expression are tightly correlated throughout infection with SARS-CoV-2 (<xref ref-type="fig" rid="F4">Figure 4D</xref>). These findings were also seen in rSARS-CoV-2 ORF6 M58R infected ACE2-expressing A549 cells (<xref ref-type="supplementary-material" rid="SD1">Supplemental Figure 2A, C</xref>). Importantly we showed that this trend was less clear in methods with suboptimal detection of SARS-CoV-2 RNAs, i.e., 10X 3′ and 10X 5′, which supports the utility of our method in studying viral gene expression at single-cell resolution (<xref ref-type="fig" rid="F4">Figure 4D</xref>).</p><p id="P32">Using our infection classification, we performed differential expression testing of infected Vero E6 cells compared to bystander cells within the same culture as well as to cells from a mock culture. As previously described (<xref ref-type="bibr" rid="R35">35</xref>), we observed suppression of many host genes in infected cells accompanied by an upregulation of cellular stress response genes (<xref ref-type="supplementary-material" rid="SD1">Supplemental Figure 4A, B</xref>). We further observed that, while bystander and mock cells had similar gene expression, a small number of genes were upregulated in bystander cells compared to mock cells. This is especially notable given the inability of Vero E6 cells to produce interferons in response to viral infection (<xref ref-type="bibr" rid="R63">63</xref>). KEGG enrichment analysis of differentially expressed genes in pairwise comparisons of infected, mock, and bystander cells showed that genes previously characterized as “related to COVID19” were enriched in our infected cells supporting our method for infection classification (<xref ref-type="supplementary-material" rid="SD1">Supplemental Figure 4C</xref>).</p><p id="P33">Finally, we explored the ability of our method to detect noncanonical leader-sgmRNA junctions in single cells. Multiple studies have reported on a variety of noncanonical sgmRNA structures detected in bulk RNAseq studies of SARS-CoV-2 infection including TRS-independent sgmRNAs (<xref ref-type="bibr" rid="R12">12</xref>, <xref ref-type="bibr" rid="R13">13</xref>), but the physiological significance of these RNAs is currently incompletely understood. We hypothesized that 10X 5′ extended R1 might be able to detect junction sites corresponding to noncanonical sgmRNA structures because of its increased read coverage at expected junction sites. We observed a variety of noncanonical sgmRNA structures including TRS-independent sgmRNAs in our Vero E6 data sequenced with 10X 5′ extended R1 (<xref ref-type="supplementary-material" rid="SD1">Supplemental Figure 5</xref>). While our data were too sparse to study cell-type specific expression of sgmRNA junctions, future studies may be able to leverage 10X 5′ extended R1 to identify differential viral or host gene expression patterns associated with expression of certain sgmRNA junctions.</p></sec><sec id="S22" sec-type="discussion"><title>Discussion</title><p id="P34">In this study, we examined the ability of two commonly used scRNA-Seq methods, 10X 3′ and 10X 5′, to detect and quantify SARS-CoV-2 derived RNAs with a focus on sgmRNAs. Because of the redundant nature of coronavirus sgmRNA sequences, we developed scCoVseq, which unambiguously quantifies both sgmRNAs and gRNAs in 10X data. We found that 10X methods detect unambiguous leader-sgmRNA junction-spanning reads to different degrees. We were able to increase the detection of leader-sgmRNA junction-spanning reads by extending the length of R1 during sequencing of 10X 5′ libraries, an approach we term 10X 5′ extended R1 sequencing. We further showed that analyzing 10X 5′ with scCoVseq or sequencing 10X 5′ with extended R1 sequencing improved the correlation of single cell data with bulk RNA-Seq data. Combining 10X 5′ extended R1 with scCoVseq maximized quantification of sgmRNA UMIs compared to 10X 5′ or 10X 3′. Thus while analyzing 10X 5′ with scCoVseq or sequencing with extended R1 improved the confidence of sgmRNA quantification, the combination of 10X 5′ with extended R1 sequencing and scCoVseq also maximized the number of sgmRNAs detected per cell.</p><p id="P35">Our method enables the comparison of sgmRNA expression dynamics at single cell resolution. We observed that SARS-CoV-2 viral gene expression is highly correlated across cells, which suggests that across increasing levels of viral RNA, the relative proportions of viral RNA are maintained. This differs significantly from other viruses such as influenza (<xref ref-type="bibr" rid="R64">64</xref>, <xref ref-type="bibr" rid="R65">65</xref>) and HSV (<xref ref-type="bibr" rid="R66">66</xref>) and CMV (<xref ref-type="bibr" rid="R67">67</xref>). These differences are likely due to differences in viral genome structure resulting in differences in regulation of viral gene expression. For example, the segmented nature of influenza virus genomes can result in virions missing gene segments, which partially explains increased heterogeneity in viral gene expression in influenza-infected cells (<xref ref-type="bibr" rid="R65">65</xref>). Future studies of coronavirus gene expression dynamics may be particularly relevant for comparing viral gene expression between different cell types, coronaviruses, or between SARS-CoV-2 variants of interest, which have been described to have different kinetics of sgmRNA expression(<xref ref-type="bibr" rid="R68">68</xref>). This approach could be extended to any coronavirus or nidovirus, including future emergent novel coronaviruses.</p><p id="P36">Finally, our method can be used to examine differential junction site usage within single cells (<xref ref-type="supplementary-material" rid="SD1">Supplemental Figure 5</xref>). Several groups have identified TRS-independent SARS-CoV-2 sgmRNAs(<xref ref-type="bibr" rid="R12">12</xref>, <xref ref-type="bibr" rid="R13">13</xref>, <xref ref-type="bibr" rid="R15">15</xref>), the significance of which remain unknown. It is possible that changes in junction site usage between cell types or during the course of infection may play a role in pathogenesis.</p><p id="P37">One technical advantage of our method is that it does not require modification of “out of the box” 10X library preparation steps. It therefore does not require technical optimization and is readily available to other researchers. Other methods such as virus-inclusive scRNA-Seq (<xref ref-type="bibr" rid="R69">69</xref>–<xref ref-type="bibr" rid="R71">71</xref>), which require technical modifications or instrumentation may be less feasible for BSL-3 pathogens such as SARS-CoV-2.</p><p id="P38">It should be noted that there are some limitations to our study. With our dataset, we are unable to know the “ground truth” infection status of a cell processed for scRNA-Seq, and therefore we cannot assess the true accuracy of our method to classify infected cells. An additional limitation of our method is that quantification of viral genes with scCoVseq is dependent on accurate annotation of viral RNAs. We derived our annotation based on published empirically-defined TRS-dependent RNAs(<xref ref-type="bibr" rid="R12">12</xref>), but this does not preclude the existence of other viral RNAs at time points or in cell types not studied. Importantly, we explicitly exclude TRS-independent RNAs from our analyses. Methods such as STARsolo(<xref ref-type="bibr" rid="R61">61</xref>) or sequencing 10X libraries with long-read sequencing(<xref ref-type="bibr" rid="R65">65</xref>) may allow for detection and quantification of viral RNAs without reference annotation and irrespective of TRSs.</p></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>Supplemental Figures</label><media xlink:href="EMS140197-supplement-Supplemental_Figures.pdf" mimetype="application" mime-subtype="pdf" id="d21aAdEbB" position="anchor"/></supplementary-material></sec></body><back><ack id="S23"><title>Acknowledgments</title><p>This work was supported in part by NIH grants R21 AI149180, R01 AI151029, and U01 AI150748. P.C. was supported by the Mount Sinai Medical Scientist Training Program T32 GM007280. P.C, R.S.P., and E.J.D. were supported by the Viral Host Pathogenesis Training Grant T32 AI07647. This work was partially supported by: CRIPT (Center for Research on Influenza Pathogenesis and Transmission), a NIAID funded Center of Excellence for Influenza Research and Response (CEIRR, contract # 75N93021C00014), NIAID grants U19 AI142733 and U19 AI135972 to A.G-S, NCI Seronet grant U54 CA260560 to A.G-S., and the JPB and OPP foundations and an anonymous philanthropic donor to A.G-S.</p><p>We thank Randy Albrecht for BSL3 facility management and support. We also thank Thomas Moran, Center for Therapeutic Antibody Discovery at the Icahn School of Medicine at Mount Sinai, for kindly providing anti-SARS-CoV Nucleocapsid antibody. We thank Michael A Schotsaert for flow cytometry support. This work was supported in part through the computational resources and staff expertise provided by Scientific Computing at the Icahn School of Medicine at Mount Sinai. Research reported in this paper was supported by the Office of Research Infrastructure of the National Institutes of Health under award number S10OD026880. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Microscopy was performed at the Microscopy CoRE at the Icahn School of Medicine at Mount Sinai. NovaSeq sequencing, bulk RNA isolation, and SMARTseq library preparation was performed at the Mount Sinai Genomics Core Facility.</p></ack><sec id="S24" sec-type="data-availability"><title>Data Availability</title><p id="P39">Raw and processed scRNA-Seq data are available at NCBI GEO (accession GSE189900) and analysis code is available at GitHub (<italic>link pending</italic>).</p></sec><fn-group><fn fn-type="conflict" id="FN1"><p id="P40"><bold>Conflicts of Interest</bold></p><p id="P41">The A.G.-S. laboratory has received research support from Pfizer, Senhwa Biosciences, Kenall Manufacturing, Blade Therapuetics, Avimex, Johnson &amp; Johnson, Dynavax, 7Hills Pharma, Pharmamar, ImmunityBio, Accurius, Nanocomposix, Hexamer, N-fold LLC, Model Medicines, Atea Pharma, Applied Biological Laboratories and Merck, outside of the reported work. A.G.-S. has consulting agreements for the following companies involving cash and/or stock: Castlevax, Amovir, Vivaldi Biosciences, Contrafect, 7Hills Pharma, Avimex, Vaxalto, Pagoda, Accurius, Esperovax, Farmak, Applied Biological Laboratories, Pharmamar, Paratus, CureLab Oncology, CureLab Veterinary, Synairgen and Pfizer, outside of the reported work. A.G.-S. has been an invited speaker in meeting events organized by Seqirus, Janssen, Abbott and Astrazeneca. A.G.-S. is inventor on patents and patent applications on the use of antivirals and vaccines for the treatment and prevention of virus infections and cancer, owned by the Icahn School of Medicine at Mount Sinai, New York.</p></fn><fn fn-type="con" id="FN2"><p id="P42"><bold>Author Contributions</bold></p><p id="P43">Conceptualization: P.C., B.R.R.</p><p id="P44">Data Curation: P.C., B.R.R.</p><p id="P45">Formal Analysis: P.C., B.R.R.</p><p id="P46">Funding Acquisition: A.G.S., B.R.R.</p><p id="P47">Investigation: P.C., E.J.D., E.B., T.K., A.C, O.D., L.M.</p><p id="P48">Methodology: P.C., B.R.R.</p><p id="P49">Project Administration: B.R.R.</p><p id="P50">Resources: A.G.S, B.R.R.</p><p id="P51">Software: P.C., R.S.P., T.B., B.R.R.,</p><p id="P52">Supervision: A.G.S., B.R.R.</p><p id="P53">Validation: P.C., R.S.P., E.J.D., O.D., T.B., E.B.,</p><p id="P54">Visualization: P.C., B.R.R.</p><p id="P55">Writing – original draft: P.C., B.R.R.</p><p id="P56">Writing – review &amp; editing: P.C., E.J.D., O.D., R.S.P., E.B., T.B., T.K., A.C., L.M., A.G.S, B.R.R.</p></fn></fn-group><ref-list><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>E</given-names></name><name><surname>Du</surname><given-names>H</given-names></name><name><surname>Gardner</surname><given-names>L</given-names></name></person-group><article-title>An interactive web-based dashboard to track COVID-19 in real time</article-title><source>Lancet Infect Dis</source><year>2020</year><volume>20</volume><fpage>533</fpage><lpage>534</lpage><pub-id pub-id-type="pmcid">PMC7159018</pub-id><pub-id pub-id-type="pmid">32087114</pub-id><pub-id pub-id-type="doi">10.1016/S1473-3099(20)30120-1</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>N</given-names></name><name><surname>Zhang</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>B</given-names></name><name><surname>Song</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>B</given-names></name><name><surname>Shi</surname><given-names>W</given-names></name><name><surname>Lu</surname><given-names>R</given-names></name><name><surname>Niu</surname><given-names>P</given-names></name><etal/></person-group><article-title>A novel coronavirus from patients with pneumonia in china, 2019</article-title><source>N Engl J Med</source><year>2020</year><volume>382</volume><fpage>727</fpage><lpage>733</lpage><pub-id pub-id-type="pmcid">PMC7092803</pub-id><pub-id pub-id-type="pmid">31978945</pub-id><pub-id pub-id-type="doi">10.1056/NEJMoa2001017</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carvalho</surname><given-names>T</given-names></name><name><surname>Krammer</surname><given-names>F</given-names></name><name><surname>Iwasaki</surname><given-names>A</given-names></name></person-group><article-title>The first 12 months of COVID-19: a timeline of immunological insights. 4</article-title><source>Nat Rev Immunol</source><year>2021</year><volume>21</volume><fpage>245</fpage><lpage>256</lpage><pub-id pub-id-type="pmcid">PMC7958099</pub-id><pub-id pub-id-type="pmid">33723416</pub-id><pub-id pub-id-type="doi">10.1038/s41577-021-00522-1</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gordon</surname><given-names>DE</given-names></name><name><surname>Jang</surname><given-names>GM</given-names></name><name><surname>Bouhaddou</surname><given-names>M</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Obernier</surname><given-names>K</given-names></name><name><surname>White</surname><given-names>KM</given-names></name><name><surname>O’Meara</surname><given-names>MJ</given-names></name><name><surname>Rezelj</surname><given-names>VV</given-names></name><name><surname>Guo</surname><given-names>JZ</given-names></name><name><surname>Swaney</surname><given-names>DL</given-names></name><name><surname>Tummino</surname><given-names>TA</given-names></name><etal/></person-group><article-title>A SARS-CoV-2 protein interaction map reveals targets for drug repurposing</article-title><source>Nature</source><year>2020</year><pub-id pub-id-type="pmcid">PMC7431030</pub-id><pub-id pub-id-type="pmid">32353859</pub-id><pub-id pub-id-type="doi">10.1038/s41586-020-2286-9</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>B</given-names></name><name><surname>Yi</surname><given-names>X</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Bi</surname><given-names>X</given-names></name><name><surname>Du</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Quan</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Sun</surname><given-names>R</given-names></name><name><surname>Qian</surname><given-names>L</given-names></name><name><surname>Ge</surname><given-names>W</given-names></name><etal/></person-group><article-title>Proteomic and metabolomic characterization of COVID-19 patient sera</article-title><year>2020</year><source>Cell</source><pub-id pub-id-type="pmcid">PMC7254001</pub-id><pub-id pub-id-type="pmid">32492406</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2020.05.032</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bojkova</surname><given-names>D</given-names></name><name><surname>Klann</surname><given-names>K</given-names></name><name><surname>Koch</surname><given-names>B</given-names></name><name><surname>Widera</surname><given-names>M</given-names></name><name><surname>Krause</surname><given-names>D</given-names></name><name><surname>Ciesek</surname><given-names>S</given-names></name><name><surname>Cinatl</surname><given-names>J</given-names></name><name><surname>Münch</surname><given-names>C</given-names></name></person-group><article-title>SARS-CoV-2 infected host cell proteomics reveal potential therapy targets</article-title><year>2020</year><pub-id pub-id-type="pmid">32408336</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finkel</surname><given-names>Y</given-names></name><name><surname>Mizrahi</surname><given-names>O</given-names></name><name><surname>Nachshon</surname><given-names>A</given-names></name><name><surname>Weingarten-Gabbay</surname><given-names>S</given-names></name><name><surname>Morgenstern</surname><given-names>D</given-names></name><name><surname>Yahalom-Ronen</surname><given-names>Y</given-names></name><name><surname>Tamir</surname><given-names>H</given-names></name><name><surname>Achdout</surname><given-names>H</given-names></name><name><surname>Stein</surname><given-names>D</given-names></name><name><surname>Israeli</surname><given-names>O</given-names></name><name><surname>Beth-Din</surname><given-names>A</given-names></name><etal/></person-group><article-title>The coding capacity of SARS-CoV-2</article-title><source>Nature</source><year>2020</year><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">32906143</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouhaddou</surname><given-names>M</given-names></name><name><surname>Memon</surname><given-names>D</given-names></name><name><surname>Meyer</surname><given-names>B</given-names></name><name><surname>White</surname><given-names>KM</given-names></name><name><surname>Rezelj</surname><given-names>VV</given-names></name><name><surname>Marrero</surname><given-names>MC</given-names></name><name><surname>Polacco</surname><given-names>BJ</given-names></name><name><surname>Melnyk</surname><given-names>JE</given-names></name><name><surname>Ulferts</surname><given-names>S</given-names></name><name><surname>Kaake</surname><given-names>RM</given-names></name><name><surname>Batra</surname><given-names>J</given-names></name><etal/></person-group><article-title>The Global Phosphorylation Landscape of SARS-CoV-2 Infection</article-title><source>Cell</source><year>2020</year><volume>0</volume><pub-id pub-id-type="pmcid">PMC7321036</pub-id><pub-id pub-id-type="pmid">32645325</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2020.06.034</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>N</given-names></name><name><surname>Lareau</surname><given-names>CA</given-names></name><name><surname>Keshishian</surname><given-names>H</given-names></name><name><surname>Ganskih</surname><given-names>S</given-names></name><name><surname>Schneider</surname><given-names>C</given-names></name><name><surname>Hennig</surname><given-names>T</given-names></name><name><surname>Melanson</surname><given-names>R</given-names></name><name><surname>Werner</surname><given-names>S</given-names></name><name><surname>Wei</surname><given-names>Y</given-names></name><name><surname>Zimmer</surname><given-names>M</given-names></name><name><surname>Ade</surname><given-names>J</given-names></name><etal/></person-group><article-title>The SARS-CoV-2 RNA– protein interactome in infected human cells. 3</article-title><source>Nat Microbiol</source><year>2021</year><volume>6</volume><fpage>339</fpage><lpage>353</lpage><pub-id pub-id-type="pmcid">PMC7906908</pub-id><pub-id pub-id-type="pmid">33349665</pub-id><pub-id pub-id-type="doi">10.1038/s41564-020-00846-z</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flynn</surname><given-names>RA</given-names></name><name><surname>Belk</surname><given-names>JA</given-names></name><name><surname>Qi</surname><given-names>Y</given-names></name><name><surname>Yasumoto</surname><given-names>Y</given-names></name><name><surname>Wei</surname><given-names>J</given-names></name><name><surname>Alfajaro</surname><given-names>MM</given-names></name><name><surname>Shi</surname><given-names>Q</given-names></name><name><surname>Mumbach</surname><given-names>MR</given-names></name><name><surname>Limaye</surname><given-names>A</given-names></name><name><surname>DeWeirdt</surname><given-names>PC</given-names></name><name><surname>Schmitz</surname><given-names>CO</given-names></name><etal/></person-group><article-title>Discovery and functional interrogation of SARS-CoV-2 RNA-host protein interactions</article-title><source>Cell</source><year>2021</year><volume>184</volume><fpage>2394</fpage><lpage>2411</lpage><elocation-id>e16</elocation-id><pub-id pub-id-type="pmcid">PMC7951565</pub-id><pub-id pub-id-type="pmid">33743211</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2021.03.012</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blanco-Melo</surname><given-names>D</given-names></name><name><surname>Nilsson-Payant</surname><given-names>BE</given-names></name><name><surname>Liu</surname><given-names>W-C</given-names></name><name><surname>Uhl</surname><given-names>S</given-names></name><name><surname>Hoagland</surname><given-names>D</given-names></name><name><surname>Møller</surname><given-names>R</given-names></name><name><surname>Jordan</surname><given-names>TX</given-names></name><name><surname>Oishi</surname><given-names>K</given-names></name><name><surname>Panis</surname><given-names>M</given-names></name><name><surname>Sachs</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>TT</given-names></name><etal/></person-group><article-title>Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19</article-title><source>Cell</source><year>2020</year><volume>181</volume><fpage>1036</fpage><lpage>1045</lpage><elocation-id>e9</elocation-id><pub-id pub-id-type="pmcid">PMC7227586</pub-id><pub-id pub-id-type="pmid">32416070</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2020.04.026</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>D</given-names></name><name><surname>Lee</surname><given-names>J-Y</given-names></name><name><surname>Yang</surname><given-names>J-S</given-names></name><name><surname>Kim</surname><given-names>JW</given-names></name><name><surname>Kim</surname><given-names>VN</given-names></name><name><surname>Chang</surname><given-names>H</given-names></name></person-group><article-title>The architecture of SARS-CoV-2 transcriptome</article-title><source>Cell</source><year>2020</year><volume>181</volume><fpage>914</fpage><lpage>921</lpage><elocation-id>e10</elocation-id><pub-id pub-id-type="pmcid">PMC7179501</pub-id><pub-id pub-id-type="pmid">32330414</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2020.04.011</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Jiang</surname><given-names>A</given-names></name><name><surname>Feng</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Guo</surname><given-names>D</given-names></name><name><surname>Sajid</surname><given-names>M</given-names></name><name><surname>Wu</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Ponty</surname><given-names>Y</given-names></name><name><surname>Will</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>F</given-names></name><etal/></person-group><article-title>The SARS-CoV-2 Subgenome Landscape and its Novel Regulatory Features</article-title><source>Mol Cell</source><year>2021</year><volume>0</volume><pub-id pub-id-type="pmcid">PMC7927579</pub-id><pub-id pub-id-type="pmid">33713597</pub-id><pub-id pub-id-type="doi">10.1016/j.molcel.2021.02.036</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ziv</surname><given-names>O</given-names></name><name><surname>Price</surname><given-names>J</given-names></name><name><surname>Shalamova</surname><given-names>L</given-names></name><name><surname>Kamenova</surname><given-names>T</given-names></name><name><surname>Goodfellow</surname><given-names>I</given-names></name><name><surname>Weber</surname><given-names>F</given-names></name><name><surname>Miska</surname><given-names>EA</given-names></name></person-group><article-title>The short- and long-range RNA-RNA Interactome of SARS-CoV-2</article-title><source>Mol Cell</source><year>2020</year><pub-id pub-id-type="pmcid">PMC7643667</pub-id><pub-id pub-id-type="pmid">33259809</pub-id><pub-id pub-id-type="doi">10.1016/j.molcel.2020.11.004</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>JJ-Y</given-names></name><name><surname>Rawlinson</surname><given-names>D</given-names></name><name><surname>Pitt</surname><given-names>ME</given-names></name><name><surname>Taiaroa</surname><given-names>G</given-names></name><name><surname>Gleeson</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>C</given-names></name><name><surname>Mordant</surname><given-names>FL</given-names></name><name><surname>Paoli-Iseppi</surname><given-names>RD</given-names></name><name><surname>Caly</surname><given-names>L</given-names></name><name><surname>Purcell</surname><given-names>DFJ</given-names></name><name><surname>Stinear</surname><given-names>TP</given-names></name><etal/></person-group><article-title>Transcriptional and epi-transcriptional dynamics of SARS-CoV-2 during cellular infection</article-title><source>Cell Rep</source><year>2021</year><volume>0</volume><pub-id pub-id-type="pmcid">PMC8062406</pub-id><pub-id pub-id-type="pmid">33961822</pub-id><pub-id pub-id-type="doi">10.1016/j.celrep.2021.109108</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bost</surname><given-names>P</given-names></name><name><surname>Giladi</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Bendjelal</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>G</given-names></name><name><surname>David</surname><given-names>E</given-names></name><name><surname>Blecher-Gonen</surname><given-names>R</given-names></name><name><surname>Cohen</surname><given-names>M</given-names></name><name><surname>Medaglia</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Deczkowska</surname><given-names>A</given-names></name><etal/></person-group><article-title>Host-viral infection maps reveal signatures of severe COVID-19 patients</article-title><source>Cell</source><year>2020</year><pub-id pub-id-type="pmcid">PMC7205692</pub-id><pub-id pub-id-type="pmid">32479746</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2020.05.006</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sungnak</surname><given-names>W</given-names></name><name><surname>Huang</surname><given-names>N</given-names></name><name><surname>Bécavin</surname><given-names>C</given-names></name><name><surname>Berg</surname><given-names>M</given-names></name><name><surname>Queen</surname><given-names>R</given-names></name><name><surname>Litvinukova</surname><given-names>M</given-names></name><name><surname>Talavera-López</surname><given-names>C</given-names></name><name><surname>Maatz</surname><given-names>H</given-names></name><name><surname>Reichart</surname><given-names>D</given-names></name><name><surname>Sampaziotis</surname><given-names>F</given-names></name><name><surname>Worlock</surname><given-names>KB</given-names></name><etal/></person-group><article-title>SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes</article-title><source>Nat Med</source><year>2020</year><volume>26</volume><fpage>681</fpage><lpage>687</lpage><pub-id pub-id-type="pmcid">PMC8637938</pub-id><pub-id pub-id-type="pmid">32327758</pub-id><pub-id pub-id-type="doi">10.1038/s41591-020-0868-6</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lukassen</surname><given-names>S</given-names></name><name><surname>Chua</surname><given-names>RL</given-names></name><name><surname>Trefzer</surname><given-names>T</given-names></name><name><surname>Kahn</surname><given-names>NC</given-names></name><name><surname>Schneider</surname><given-names>MA</given-names></name><name><surname>Muley</surname><given-names>T</given-names></name><name><surname>Winter</surname><given-names>H</given-names></name><name><surname>Meister</surname><given-names>M</given-names></name><name><surname>Veith</surname><given-names>C</given-names></name><name><surname>Boots</surname><given-names>AW</given-names></name><name><surname>Hennig</surname><given-names>BP</given-names></name><etal/></person-group><article-title>SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells</article-title><source>EMBO J</source><year>2020</year><volume>39</volume><elocation-id>e105114</elocation-id><pub-id pub-id-type="pmcid">PMC7232010</pub-id><pub-id pub-id-type="pmid">32246845</pub-id><pub-id pub-id-type="doi">10.15252/embj.20105114</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fodoulian</surname><given-names>L</given-names></name><name><surname>Tuberosa</surname><given-names>J</given-names></name><name><surname>Rossier</surname><given-names>D</given-names></name><name><surname>Landis</surname><given-names>B</given-names></name><name><surname>Carleton</surname><given-names>A</given-names></name><name><surname>Rodriguez</surname><given-names>I</given-names></name></person-group><article-title>SARS-CoV-2 receptor and entry genes are expressed by sustentacular cells in the human olfactory neuroepithelium</article-title><source>BioRxiv</source><year>2020</year><pub-id pub-id-type="pmcid">PMC7685946</pub-id><pub-id pub-id-type="pmid">33251489</pub-id><pub-id pub-id-type="doi">10.1016/j.isci.2020.101839</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qi</surname><given-names>F</given-names></name><name><surname>Qian</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name></person-group><article-title>Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses</article-title><source>Biochem Biophys Res Commun</source><year>2020</year><volume>526</volume><fpage>135</fpage><lpage>140</lpage><pub-id pub-id-type="pmcid">PMC7156119</pub-id><pub-id pub-id-type="pmid">32199615</pub-id><pub-id pub-id-type="doi">10.1016/j.bbrc.2020.03.044</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ravindra</surname><given-names>NG</given-names></name><name><surname>Alfajaro</surname><given-names>MM</given-names></name><name><surname>Gasque</surname><given-names>V</given-names></name><name><surname>Huston</surname><given-names>NC</given-names></name><name><surname>Wan</surname><given-names>H</given-names></name><name><surname>Szigeti-Buck</surname><given-names>K</given-names></name><name><surname>Yasumoto</surname><given-names>Y</given-names></name><name><surname>Greaney</surname><given-names>AM</given-names></name><name><surname>Habet</surname><given-names>V</given-names></name><name><surname>Chow</surname><given-names>RD</given-names></name><name><surname>Chen</surname><given-names>JS</given-names></name><etal/></person-group><article-title>Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium identifies target cells, alterations in gene expression, and cell state changes</article-title><source>PLOS Biol</source><year>2021</year><volume>19</volume><elocation-id>e3001143</elocation-id><pub-id pub-id-type="pmcid">PMC8007021</pub-id><pub-id pub-id-type="pmid">33730024</pub-id><pub-id pub-id-type="doi">10.1371/journal.pbio.3001143</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muus</surname><given-names>C</given-names></name><name><surname>Luecken</surname><given-names>MD</given-names></name><name><surname>Eraslan</surname><given-names>G</given-names></name><name><surname>Sikkema</surname><given-names>L</given-names></name><name><surname>Waghray</surname><given-names>A</given-names></name><name><surname>Heimberg</surname><given-names>G</given-names></name><name><surname>Kobayashi</surname><given-names>Y</given-names></name><name><surname>Vaishnav</surname><given-names>ED</given-names></name><name><surname>Subramanian</surname><given-names>A</given-names></name><name><surname>Smillie</surname><given-names>C</given-names></name><name><surname>Jagadeesh</surname><given-names>KA</given-names></name><etal/></person-group><article-title>Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics. 3</article-title><source>Nat Med</source><year>2021</year><volume>27</volume><fpage>546</fpage><lpage>559</lpage><pub-id pub-id-type="pmcid">PMC9469728</pub-id><pub-id pub-id-type="pmid">33654293</pub-id><pub-id pub-id-type="doi">10.1038/s41591-020-01227-z</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bieberich</surname><given-names>F</given-names></name><name><surname>Vazquez-Lombardi</surname><given-names>R</given-names></name><name><surname>Yermanos</surname><given-names>A</given-names></name><name><surname>Ehling</surname><given-names>RA</given-names></name><name><surname>Mason</surname><given-names>DM</given-names></name><name><surname>Wagner</surname><given-names>B</given-names></name><name><surname>Kapetanovic</surname><given-names>E</given-names></name><name><surname>Roberto</surname><given-names>RBD</given-names></name><name><surname>Weber</surname><given-names>CR</given-names></name><name><surname>Savic</surname><given-names>M</given-names></name><name><surname>Rudolf</surname><given-names>F</given-names></name><etal/></person-group><article-title>A single-cell atlas of lymphocyte adaptive immune repertoires and transcriptomes reveals age-related differences in convalescent COVID-19 patients</article-title><source>bioRxiv</source><year>2021</year><elocation-id>2021.02.12.430907</elocation-id><pub-id pub-id-type="pmcid">PMC8312723</pub-id><pub-id pub-id-type="pmid">34322127</pub-id><pub-id pub-id-type="doi">10.3389/fimmu.2021.701085</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilk</surname><given-names>AJ</given-names></name><name><surname>Rustagi</surname><given-names>A</given-names></name><name><surname>Zhao</surname><given-names>NQ</given-names></name><name><surname>Roque</surname><given-names>J</given-names></name><name><surname>Martínez-Colón</surname><given-names>GJ</given-names></name><name><surname>McKechnie</surname><given-names>JL</given-names></name><name><surname>Ivison</surname><given-names>GT</given-names></name><name><surname>Ranganath</surname><given-names>T</given-names></name><name><surname>Vergara</surname><given-names>R</given-names></name><name><surname>Hollis</surname><given-names>T</given-names></name><name><surname>Simpson</surname><given-names>LJ</given-names></name><etal/></person-group><article-title>A single-cell atlas of the peripheral immune response in patients with severe COVID-19. 7</article-title><source>Nat Med</source><year>2020</year><volume>26</volume><fpage>1070</fpage><lpage>1076</lpage><pub-id pub-id-type="pmcid">PMC7382903</pub-id><pub-id pub-id-type="pmid">32514174</pub-id><pub-id pub-id-type="doi">10.1038/s41591-020-0944-y</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>C</given-names></name><name><surname>Bora</surname><given-names>SA</given-names></name><name><surname>Parimon</surname><given-names>T</given-names></name><name><surname>Zaman</surname><given-names>T</given-names></name><name><surname>Friedman</surname><given-names>OA</given-names></name><name><surname>Palatinus</surname><given-names>JA</given-names></name><name><surname>Surapaneni</surname><given-names>NS</given-names></name><name><surname>Matusov</surname><given-names>YP</given-names></name><name><surname>Chiang</surname><given-names>GC</given-names></name><name><surname>Kassar</surname><given-names>AG</given-names></name><name><surname>Patel</surname><given-names>N</given-names></name><etal/></person-group><article-title>Cell-Type-Specific Immune Dysregulation in Severely Ill COVID-19 Patients</article-title><source>Cell Rep</source><year>2021</year><volume>34</volume><pub-id pub-id-type="pmcid">PMC7744012</pub-id><pub-id pub-id-type="pmid">33357411</pub-id><pub-id pub-id-type="doi">10.1016/j.celrep.2020.108590</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacDonald</surname><given-names>L</given-names></name><name><surname>Otto</surname><given-names>TD</given-names></name><name><surname>Elmesmari</surname><given-names>A</given-names></name><name><surname>Tolusso</surname><given-names>B</given-names></name><name><surname>Somma</surname><given-names>D</given-names></name><name><surname>McSharry</surname><given-names>C</given-names></name><name><surname>Gremese</surname><given-names>E</given-names></name><name><surname>McInnes</surname><given-names>IB</given-names></name><name><surname>Alivernini</surname><given-names>S</given-names></name><name><surname>Kurowska-Stolarska</surname><given-names>M</given-names></name></person-group><article-title>COVID-19 and Rheumatoid Arthritis share myeloid pathogenic and resolving pathways</article-title><source>bioRxiv</source><year>2020</year><elocation-id>2020.07.26.221572</elocation-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schreibing</surname><given-names>F</given-names></name><name><surname>Hannani</surname><given-names>M</given-names></name><name><surname>Ticconi</surname><given-names>F</given-names></name><name><surname>Fewings</surname><given-names>E</given-names></name><name><surname>Nagai</surname><given-names>JS</given-names></name><name><surname>Begemann</surname><given-names>M</given-names></name><name><surname>Kuppe</surname><given-names>C</given-names></name><name><surname>Kurth</surname><given-names>I</given-names></name><name><surname>Kranz</surname><given-names>J</given-names></name><name><surname>Frank</surname><given-names>D</given-names></name><name><surname>Anslinger</surname><given-names>TM</given-names></name><etal/></person-group><article-title>Dissecting CD8+ T cell pathology of severe SARS-CoV-2 infection by single-cell epitope mapping</article-title><source>bioRxiv</source><year>2021</year><elocation-id>2021.03.03.432690</elocation-id><pub-id pub-id-type="pmcid">PMC9800604</pub-id><pub-id pub-id-type="pmid">36591270</pub-id><pub-id pub-id-type="doi">10.3389/fimmu.2022.1066176</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wen</surname><given-names>W</given-names></name><name><surname>Su</surname><given-names>W</given-names></name><name><surname>Tang</surname><given-names>H</given-names></name><name><surname>Le</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Xie</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Ye</surname><given-names>J</given-names></name><name><surname>Dong</surname><given-names>L</given-names></name><etal/></person-group><article-title>Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing</article-title><source>Cell Discov</source><year>2020</year><volume>6</volume><fpage>31</fpage><pub-id pub-id-type="pmcid">PMC7197635</pub-id><pub-id pub-id-type="pmid">32377375</pub-id><pub-id pub-id-type="doi">10.1038/s41421-020-0168-9</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JS</given-names></name><name><surname>Park</surname><given-names>S</given-names></name><name><surname>Jeong</surname><given-names>HW</given-names></name><name><surname>Ahn</surname><given-names>JY</given-names></name><name><surname>Choi</surname><given-names>SJ</given-names></name><name><surname>Lee</surname><given-names>H</given-names></name><name><surname>Choi</surname><given-names>B</given-names></name><name><surname>Nam</surname><given-names>SK</given-names></name><name><surname>Sa</surname><given-names>M</given-names></name><name><surname>Kwon</surname><given-names>J-S</given-names></name><name><surname>Jeong</surname><given-names>SJ</given-names></name><etal/></person-group><article-title>Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19</article-title><source>Sci Immunol</source><year>2020</year><volume>5</volume><pub-id pub-id-type="pmcid">PMC7402635</pub-id><pub-id pub-id-type="pmid">32651212</pub-id><pub-id pub-id-type="doi">10.1126/sciimmunol.abd1554</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>F-S</given-names></name><name><surname>Zhang</surname><given-names>J-Y</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Xing</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Song</surname><given-names>J-W</given-names></name><name><surname>Fan</surname><given-names>X</given-names></name><name><surname>Xia</surname><given-names>P</given-names></name><name><surname>Fu</surname><given-names>J-L</given-names></name><name><surname>Wang</surname><given-names>S-Y</given-names></name><etal/></person-group><article-title>Single-cell landscape of immunological responses in COVID-19 patients</article-title><source>bioRxiv</source><year>2020</year><elocation-id>2020.07.23.217703</elocation-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J-Y</given-names></name><name><surname>Wang</surname><given-names>X-M</given-names></name><name><surname>Xing</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Song</surname><given-names>J-W</given-names></name><name><surname>Fan</surname><given-names>X</given-names></name><name><surname>Xia</surname><given-names>P</given-names></name><name><surname>Fu</surname><given-names>J-L</given-names></name><name><surname>Wang</surname><given-names>S-Y</given-names></name><name><surname>Xu</surname><given-names>R-N</given-names></name><etal/></person-group><article-title>Single-cell landscape of immunological responses in patients with COVID-19. 9</article-title><source>Nat Immunol</source><year>2020</year><volume>21</volume><fpage>1107</fpage><lpage>1118</lpage><pub-id pub-id-type="pmid">32788748</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalfaoglu</surname><given-names>B</given-names></name><name><surname>Almeida-Santos</surname><given-names>J</given-names></name><name><surname>Tye</surname><given-names>CA</given-names></name><name><surname>Satou</surname><given-names>Y</given-names></name><name><surname>Ono</surname><given-names>M</given-names></name></person-group><article-title>T-cell hyperactivation and paralysis in severe COVID-19 infection revealed by single-cell analysis</article-title><source>BioRxiv</source><year>2020</year><pub-id pub-id-type="pmcid">PMC7596772</pub-id><pub-id pub-id-type="pmid">33178221</pub-id><pub-id pub-id-type="doi">10.3389/fimmu.2020.589380</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>L</given-names></name><name><surname>Ming</surname><given-names>S</given-names></name><name><surname>Zou</surname><given-names>B</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Hong</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Zheng</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>M</given-names></name><name><surname>Luo</surname><given-names>L</given-names></name><name><surname>Liang</surname><given-names>J</given-names></name><name><surname>Wen</surname><given-names>X</given-names></name><etal/></person-group><article-title>Viral invasion and type I interferon response characterize the immunophenotypes during COVID-19 infection</article-title><source>Electron J</source><year>2020</year><pub-id pub-id-type="doi">10.2139/ssrn.3555695</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wyler</surname><given-names>E</given-names></name><name><surname>Mösbauer</surname><given-names>K</given-names></name><name><surname>Franke</surname><given-names>V</given-names></name><name><surname>Diag</surname><given-names>A</given-names></name><name><surname>Gottula</surname><given-names>LT</given-names></name><name><surname>Arsie</surname><given-names>R</given-names></name><name><surname>Klironomos</surname><given-names>F</given-names></name><name><surname>Koppstein</surname><given-names>D</given-names></name><name><surname>Ayoub</surname><given-names>S</given-names></name><name><surname>Buccitelli</surname><given-names>C</given-names></name><name><surname>Richter</surname><given-names>A</given-names></name><etal/></person-group><article-title>Bulk and single-cell gene expression profiling of SARS-CoV-2 infected human cell lines identifies molecular targets for therapeutic intervention</article-title><source>BioRxiv</source><year>2020</year><pub-id pub-id-type="doi">10.1101/2020.05.05.079194</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miorin</surname><given-names>L</given-names></name><name><surname>Kehrer</surname><given-names>T</given-names></name><name><surname>Sanchez-Aparicio</surname><given-names>MT</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Cohen</surname><given-names>P</given-names></name><name><surname>Patel</surname><given-names>RS</given-names></name><name><surname>Cupic</surname><given-names>A</given-names></name><name><surname>Makio</surname><given-names>T</given-names></name><name><surname>Mei</surname><given-names>M</given-names></name><name><surname>Moreno</surname><given-names>E</given-names></name><name><surname>Danziger</surname><given-names>O</given-names></name><etal/></person-group><article-title>SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling</article-title><source>Proc Natl Acad Sci</source><year>2020</year><volume>117</volume><fpage>28344</fpage><lpage>28354</lpage><pub-id pub-id-type="pmcid">PMC7668094</pub-id><pub-id pub-id-type="pmid">33097660</pub-id><pub-id pub-id-type="doi">10.1073/pnas.2016650117</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melms</surname><given-names>JC</given-names></name><name><surname>Biermann</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Nair</surname><given-names>A</given-names></name><name><surname>Tagore</surname><given-names>S</given-names></name><name><surname>Katsyv</surname><given-names>I</given-names></name><name><surname>Rendeiro</surname><given-names>AF</given-names></name><name><surname>Amin</surname><given-names>AD</given-names></name><name><surname>Schapiro</surname><given-names>D</given-names></name><name><surname>Frangieh</surname><given-names>CJ</given-names></name><etal/></person-group><article-title>A molecular single-cell lung atlas of lethal COVID-19</article-title><source>Nature</source><year>2021</year><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="pmcid">PMC8814825</pub-id><pub-id pub-id-type="pmid">33915568</pub-id><pub-id pub-id-type="doi">10.1038/s41586-021-03569-1</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delorey</surname><given-names>TM</given-names></name><name><surname>Ziegler</surname><given-names>CGK</given-names></name><name><surname>Heimberg</surname><given-names>G</given-names></name><name><surname>Normand</surname><given-names>R</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Segerstolpe</surname><given-names>Å</given-names></name><name><surname>Abbondanza</surname><given-names>D</given-names></name><name><surname>Fleming</surname><given-names>SJ</given-names></name><name><surname>Subramanian</surname><given-names>A</given-names></name><name><surname>Montoro</surname><given-names>DT</given-names></name><name><surname>Jagadeesh</surname><given-names>KA</given-names></name><etal/></person-group><article-title>COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets</article-title><source>Nature</source><year>2021</year><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="pmcid">PMC8919505</pub-id><pub-id pub-id-type="pmid">33915569</pub-id><pub-id pub-id-type="doi">10.1038/s41586-021-03570-8</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harrison</surname><given-names>AG</given-names></name><name><surname>Lin</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name></person-group><article-title>Mechanisms of SARS-CoV-2 Transmission and Pathogenesis</article-title><source>Trends Immunol</source><year>2020</year><volume>41</volume><fpage>1100</fpage><lpage>1115</lpage><pub-id pub-id-type="pmcid">PMC7556779</pub-id><pub-id pub-id-type="pmid">33132005</pub-id><pub-id pub-id-type="doi">10.1016/j.it.2020.10.004</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>V’kovski</surname><given-names>P</given-names></name><name><surname>Kratzel</surname><given-names>A</given-names></name><name><surname>Steiner</surname><given-names>S</given-names></name><name><surname>Stalder</surname><given-names>H</given-names></name><name><surname>Thiel</surname><given-names>V</given-names></name></person-group><article-title>Coronavirus biology and replication: implications for SARS-CoV-2. 3</article-title><source>Nat Rev Microbiol</source><year>2020</year><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="pmcid">PMC7592455</pub-id><pub-id pub-id-type="pmid">33116300</pub-id><pub-id pub-id-type="doi">10.1038/s41579-020-00468-6</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sola</surname><given-names>I</given-names></name><name><surname>Almazán</surname><given-names>F</given-names></name><name><surname>Zúñiga</surname><given-names>S</given-names></name><name><surname>Enjuanes</surname><given-names>L</given-names></name></person-group><article-title>Continuous and discontinuous RNA synthesis in coronaviruses</article-title><source>Annu Rev Virol</source><year>2015</year><volume>2</volume><fpage>265</fpage><lpage>288</lpage><pub-id pub-id-type="pmcid">PMC6025776</pub-id><pub-id pub-id-type="pmid">26958916</pub-id><pub-id pub-id-type="doi">10.1146/annurev-virology-100114-055218</pub-id></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Perlman</surname><given-names>S</given-names></name><name><surname>Masters</surname><given-names>PS</given-names></name></person-group><chapter-title>Coronaviridae: The Viruses and Their Replication</chapter-title><fpage>411</fpage><lpage>442</lpage><person-group person-group-type="editor"><name><surname>Howley</surname><given-names>PM</given-names></name><name><surname>Knipe</surname><given-names>DM</given-names></name><name><surname>Whelan</surname><given-names>S</given-names></name></person-group><source>Fields Virology: Emerging Viruses</source><year>2020</year><edition>7th ed</edition><publisher-name>Wolters Kluwer Health/lippincott Williams &amp; Wilkins</publisher-name><publisher-loc>Philadelphia, PA</publisher-loc></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parker</surname><given-names>MD</given-names></name><name><surname>Lindsey</surname><given-names>BB</given-names></name><name><surname>Leary</surname><given-names>S</given-names></name><name><surname>Gaudieri</surname><given-names>S</given-names></name><name><surname>Chopra</surname><given-names>A</given-names></name><name><surname>Wyles</surname><given-names>M</given-names></name><name><surname>Angyal</surname><given-names>A</given-names></name><name><surname>Green</surname><given-names>LR</given-names></name><name><surname>Parsons</surname><given-names>P</given-names></name><name><surname>Tucker</surname><given-names>RM</given-names></name><name><surname>Brown</surname><given-names>R</given-names></name><etal/></person-group><article-title>Subgenomic RNA identification in SARS-CoV-2 genomic sequencing data</article-title><source>Genome Res</source><year>2021</year><volume>31</volume><fpage>645</fpage><lpage>658</lpage><pub-id pub-id-type="pmcid">PMC8015849</pub-id><pub-id pub-id-type="pmid">33722935</pub-id><pub-id pub-id-type="doi">10.1101/gr.268110.120</pub-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daniloski</surname><given-names>Z</given-names></name><name><surname>Jordan</surname><given-names>TX</given-names></name><name><surname>Wessels</surname><given-names>H-H</given-names></name><name><surname>Hoagland</surname><given-names>DA</given-names></name><name><surname>Kasela</surname><given-names>S</given-names></name><name><surname>Legut</surname><given-names>M</given-names></name><name><surname>Maniatis</surname><given-names>S</given-names></name><name><surname>Mimitou</surname><given-names>EP</given-names></name><name><surname>Lu</surname><given-names>L</given-names></name><name><surname>Geller</surname><given-names>E</given-names></name><name><surname>Danziger</surname><given-names>O</given-names></name><etal/></person-group><article-title>Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells</article-title><source>Cell</source><year>2021</year><volume>184</volume><fpage>92</fpage><lpage>105</lpage><elocation-id>e16</elocation-id><pub-id pub-id-type="pmcid">PMC7584921</pub-id><pub-id pub-id-type="pmid">33147445</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2020.10.030</pub-id></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miorin</surname><given-names>L</given-names></name><name><surname>Mire</surname><given-names>CE</given-names></name><name><surname>Ranjbar</surname><given-names>S</given-names></name><name><surname>Hume</surname><given-names>AJ</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Crossland</surname><given-names>NA</given-names></name><name><surname>White</surname><given-names>KM</given-names></name><name><surname>Laporte</surname><given-names>M</given-names></name><name><surname>Kehrer</surname><given-names>T</given-names></name><name><surname>Haridas</surname><given-names>V</given-names></name><name><surname>Moreno</surname><given-names>E</given-names></name><etal/></person-group><article-title>The oral drug nitazoxanide restricts SARS-CoV-2 infection and attenuates disease pathogenesis in Syrian hamsters</article-title><source>bioRxiv</source><year>2022</year><pub-id pub-id-type="doi">10.1101/2022.02.08.479634</pub-id></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kehrer</surname><given-names>T</given-names></name><name><surname>Cupic</surname><given-names>A</given-names></name><name><surname>Ye</surname><given-names>C</given-names></name><name><surname>Yildiz</surname><given-names>S</given-names></name><name><surname>Bouhhadou</surname><given-names>M</given-names></name><name><surname>Crossland</surname><given-names>NA</given-names></name><name><surname>Barrall</surname><given-names>E</given-names></name><name><surname>Cohen</surname><given-names>P</given-names></name><name><surname>Tseng</surname><given-names>A</given-names></name><name><surname>Çağatay</surname><given-names>T</given-names></name><name><surname>Rathnasinghe</surname><given-names>R</given-names></name><etal/></person-group><article-title>Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis</article-title><source>bioRxiv</source><year>2022</year><pub-id pub-id-type="doi">10.1101/2022.10.18.512708</pub-id></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez-Reiche</surname><given-names>AS</given-names></name><name><surname>Hernandez</surname><given-names>MM</given-names></name><name><surname>Sullivan</surname><given-names>MJ</given-names></name><name><surname>Ciferri</surname><given-names>B</given-names></name><name><surname>Alshammary</surname><given-names>H</given-names></name><name><surname>Obla</surname><given-names>A</given-names></name><name><surname>Fabre</surname><given-names>S</given-names></name><name><surname>Kleiner</surname><given-names>G</given-names></name><name><surname>Polanco</surname><given-names>J</given-names></name><name><surname>Khan</surname><given-names>Z</given-names></name><name><surname>Alburquerque</surname><given-names>B</given-names></name><etal/></person-group><article-title>Introductions and early spread of SARS-CoV-2 in the New York City area</article-title><source>Science</source><year>2020</year><pub-id pub-id-type="pmcid">PMC7259823</pub-id><pub-id pub-id-type="pmid">32471856</pub-id><pub-id pub-id-type="doi">10.1126/science.abc1917</pub-id></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Escalera</surname><given-names>A</given-names></name><name><surname>Gonzalez-Reiche</surname><given-names>AS</given-names></name><name><surname>Aslam</surname><given-names>S</given-names></name><name><surname>Mena</surname><given-names>I</given-names></name><name><surname>Laporte</surname><given-names>M</given-names></name><name><surname>Pearl</surname><given-names>RL</given-names></name><name><surname>Fossati</surname><given-names>A</given-names></name><name><surname>Rathnasinghe</surname><given-names>R</given-names></name><name><surname>Alshammary</surname><given-names>H</given-names></name><name><surname>van de Guchte</surname><given-names>A</given-names></name><name><surname>Farrugia</surname><given-names>K</given-names></name><etal/></person-group><article-title>Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission</article-title><source>Cell Host Microbe</source><year>2022</year><volume>30</volume><fpage>373</fpage><lpage>387</lpage><elocation-id>e7</elocation-id><pub-id pub-id-type="pmcid">PMC8776496</pub-id><pub-id pub-id-type="pmid">35150638</pub-id><pub-id pub-id-type="doi">10.1016/j.chom.2022.01.006</pub-id></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macosko</surname><given-names>EZ</given-names></name><name><surname>Basu</surname><given-names>A</given-names></name><name><surname>Satija</surname><given-names>R</given-names></name><name><surname>Nemesh</surname><given-names>J</given-names></name><name><surname>Shekhar</surname><given-names>K</given-names></name><name><surname>Goldman</surname><given-names>M</given-names></name><name><surname>Tirosh</surname><given-names>I</given-names></name><name><surname>Bialas</surname><given-names>AR</given-names></name><name><surname>Kamitaki</surname><given-names>N</given-names></name><name><surname>Martersteck</surname><given-names>EM</given-names></name><name><surname>Trombetta</surname><given-names>JJ</given-names></name><etal/></person-group><article-title>Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets</article-title><source>Cell</source><year>2015</year><volume>161</volume><fpage>1202</fpage><lpage>1214</lpage><pub-id pub-id-type="pmcid">PMC4481139</pub-id><pub-id pub-id-type="pmid">26000488</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2015.05.002</pub-id></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butler</surname><given-names>A</given-names></name><name><surname>Hoffman</surname><given-names>P</given-names></name><name><surname>Smibert</surname><given-names>P</given-names></name><name><surname>Papalexi</surname><given-names>E</given-names></name><name><surname>Satija</surname><given-names>R</given-names></name></person-group><article-title>Integrating single-cell transcriptomic data across different conditions, technologies, and species</article-title><source>Nat Biotechnol</source><year>2018</year><volume>36</volume><fpage>411</fpage><lpage>420</lpage><pub-id pub-id-type="pmcid">PMC6700744</pub-id><pub-id pub-id-type="pmid">29608179</pub-id><pub-id pub-id-type="doi">10.1038/nbt.4096</pub-id></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hafemeister</surname><given-names>C</given-names></name><name><surname>Satija</surname><given-names>R</given-names></name></person-group><article-title>Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression</article-title><source>Genome Biol</source><year>2019</year><volume>20</volume><fpage>296</fpage><pub-id pub-id-type="pmcid">PMC6927181</pub-id><pub-id pub-id-type="pmid">31870423</pub-id><pub-id pub-id-type="doi">10.1186/s13059-019-1874-1</pub-id></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="other"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H</given-names></name></person-group><source>lh3/seqtk. C</source><year>2021</year></element-citation></ref><ref id="R52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandes</surname><given-names>JD</given-names></name><name><surname>Hinrichs</surname><given-names>AS</given-names></name><name><surname>Clawson</surname><given-names>H</given-names></name><name><surname>Navarro Gonzalez</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>BT</given-names></name><name><surname>Nassar</surname><given-names>LR</given-names></name><name><surname>Raney</surname><given-names>BJ</given-names></name><name><surname>Rosenbloom</surname><given-names>KR</given-names></name><name><surname>Nerli</surname><given-names>S</given-names></name><name><surname>Rao</surname><given-names>A</given-names></name><name><surname>Schmelter</surname><given-names>D</given-names></name><etal/></person-group><article-title>The UCSC SARS-CoV-2 genome browser</article-title><source>BioRxiv</source><year>2020</year><pub-id pub-id-type="pmcid">PMC8016453</pub-id><pub-id pub-id-type="pmid">32908258</pub-id><pub-id pub-id-type="doi">10.1038/s41588-020-0700-8</pub-id></element-citation></ref><ref id="R53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Danecek</surname><given-names>P</given-names></name><name><surname>Bonfield</surname><given-names>JK</given-names></name><name><surname>Liddle</surname><given-names>J</given-names></name><name><surname>Marshall</surname><given-names>J</given-names></name><name><surname>Ohan</surname><given-names>V</given-names></name><name><surname>Pollard</surname><given-names>MO</given-names></name><name><surname>Whitwham</surname><given-names>A</given-names></name><name><surname>Keane</surname><given-names>T</given-names></name><name><surname>McCarthy</surname><given-names>SA</given-names></name><name><surname>Davies</surname><given-names>RM</given-names></name><name><surname>Li</surname><given-names>H</given-names></name></person-group><article-title>Twelve years of SAMtools and BCFtools</article-title><source>GigaScience</source><year>2021</year><volume>10</volume><elocation-id>giab008</elocation-id><pub-id pub-id-type="pmcid">PMC7931819</pub-id><pub-id pub-id-type="pmid">33590861</pub-id><pub-id pub-id-type="doi">10.1093/gigascience/giab008</pub-id></element-citation></ref><ref id="R54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>T</given-names></name><name><surname>Heger</surname><given-names>A</given-names></name><name><surname>Sudbery</surname><given-names>I</given-names></name></person-group><article-title>UMI-tools: modeling sequencing errors in Unique Molecular Identifiers to improve quantification accuracy</article-title><source>Genome Res</source><year>2017</year><volume>27</volume><fpage>491</fpage><lpage>499</lpage><pub-id pub-id-type="pmcid">PMC5340976</pub-id><pub-id pub-id-type="pmid">28100584</pub-id><pub-id pub-id-type="doi">10.1101/gr.209601.116</pub-id></element-citation></ref><ref id="R55"><label>55</label><element-citation publication-type="web"><collab>Sparse and Dense Matrix Classes and Methods [R package Matrix version 1.3-4]</collab><year>2021</year><source>Comprehensive R Archive Network (CRAN)</source><comment><ext-link ext-link-type="uri" xlink:href="https://CRAN.R-project.org/package=Matrix">https://CRAN.R-project.org/package=Matrix</ext-link>, Retrieved 3 June 2021</comment></element-citation></ref><ref id="R56"><label>56</label><element-citation publication-type="web"><collab>Read Rectangular Text Data [R package readr version 1.4.0]</collab><source>Comprehensive R Archive Network (CRAN)</source><year>2020</year><comment><ext-link ext-link-type="uri" xlink:href="https://CRAN.R-project.org/package=readr">https://CRAN.R-project.org/package=readr</ext-link>. Retrieved 3 June 2021</comment></element-citation></ref><ref id="R57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garrido-Martín</surname><given-names>D</given-names></name><name><surname>Palumbo</surname><given-names>E</given-names></name><name><surname>Guigó</surname><given-names>R</given-names></name><name><surname>Breschi</surname><given-names>A</given-names></name></person-group><article-title>ggsashimi: Sashimi plot revised for browser- and annotation-independent splicing visualization</article-title><source>PLOS Comput Biol</source><year>2018</year><volume>14</volume><elocation-id>e1006360</elocation-id><pub-id pub-id-type="pmcid">PMC6114895</pub-id><pub-id pub-id-type="pmid">30118475</pub-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1006360</pub-id></element-citation></ref><ref id="R58"><label>58</label><element-citation publication-type="other"><person-group person-group-type="author"><name><surname>Maechler</surname><given-names>M</given-names></name><collab>original) PR (Fortran, original) AS (S, original) MH (S, Hornik [trl K, maintenance(1999-2000)) ctb] (port to R, Studer M, Roudier P, Gonzalez J, Kozlowski K, pam()) ES (fastpam options for, Murphy (volume.ellipsoid({d &gt;= 3})) K</collab></person-group><source>cluster: “Finding Groups in Data”: Cluster Analysis Extended Rousseeuw et al. (2.1.2)</source><year>2021</year></element-citation></ref><ref id="R59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>MD</given-names></name><name><surname>McCarthy</surname><given-names>DJ</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name></person-group><article-title>edgeR: a Bioconductor package for differential expression analysis of digital gene expression data</article-title><source>Bioinformatics</source><year>2010</year><volume>26</volume><fpage>139</fpage><lpage>140</lpage><pub-id pub-id-type="pmcid">PMC2796818</pub-id><pub-id pub-id-type="pmid">19910308</pub-id><pub-id pub-id-type="doi">10.1093/bioinformatics/btp616</pub-id></element-citation></ref><ref id="R60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soneson</surname><given-names>C</given-names></name><name><surname>Robinson</surname><given-names>MD</given-names></name></person-group><article-title>Bias, robustness and scalability in single-cell differential expression analysis. 4</article-title><source>Nat Methods</source><year>2018</year><volume>15</volume><fpage>255</fpage><lpage>261</lpage><pub-id pub-id-type="pmid">29481549</pub-id></element-citation></ref><ref id="R61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaminow</surname><given-names>B</given-names></name><name><surname>Yunusov</surname><given-names>D</given-names></name><name><surname>Dobin</surname><given-names>A</given-names></name></person-group><article-title>STARsolo: accurate, fast and versatile mapping/quantification of single-cell and single-nucleus RNA-seq data</article-title><source>bioRxiv</source><year>2021</year><elocation-id>2021.05.05.442755</elocation-id></element-citation></ref><ref id="R62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McQuin</surname><given-names>C</given-names></name><name><surname>Goodman</surname><given-names>A</given-names></name><name><surname>Chernyshev</surname><given-names>V</given-names></name><name><surname>Kamentsky</surname><given-names>L</given-names></name><name><surname>Cimini</surname><given-names>BA</given-names></name><name><surname>Karhohs</surname><given-names>KW</given-names></name><name><surname>Doan</surname><given-names>M</given-names></name><name><surname>Ding</surname><given-names>L</given-names></name><name><surname>Rafelski</surname><given-names>SM</given-names></name><name><surname>Thirstrup</surname><given-names>D</given-names></name><name><surname>Wiegraebe</surname><given-names>W</given-names></name><name><surname>Singh</surname><given-names>S</given-names></name><name><surname>Becker</surname><given-names>T</given-names></name><name><surname>Caicedo</surname><given-names>JC</given-names></name><name><surname>Carpenter</surname><given-names>AE</given-names></name></person-group><article-title>CellProfiler 3.0: Next-generation image processing for biology</article-title><source>PLOS Biol</source><year>2018</year><volume>16</volume><elocation-id>e2005970</elocation-id><pub-id pub-id-type="pmcid">PMC6029841</pub-id><pub-id pub-id-type="pmid">29969450</pub-id><pub-id pub-id-type="doi">10.1371/journal.pbio.2005970</pub-id></element-citation></ref><ref id="R63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emeny</surname><given-names>JM</given-names></name><name><surname>Morgan</surname><given-names>MJY</given-names></name></person-group><article-title>Regulation of the Interferon System: Evidence that Vero Cells have a Genetic Defect in Interferon Production</article-title><source>J Gen Virol</source><year>1979</year><volume>43</volume><fpage>247</fpage><lpage>252</lpage><pub-id pub-id-type="pmid">113494</pub-id></element-citation></ref><ref id="R64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russell</surname><given-names>AB</given-names></name><name><surname>Trapnell</surname><given-names>C</given-names></name><name><surname>Bloom</surname><given-names>JD</given-names></name></person-group><article-title>Extreme heterogeneity of influenza virus infection in single cells</article-title><source>eLife</source><year>2018</year><volume>7</volume><elocation-id>e32303</elocation-id><pub-id pub-id-type="pmcid">PMC5826275</pub-id><pub-id pub-id-type="pmid">29451492</pub-id><pub-id pub-id-type="doi">10.7554/eLife.32303</pub-id></element-citation></ref><ref id="R65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russell</surname><given-names>AB</given-names></name><name><surname>Elshina</surname><given-names>E</given-names></name><name><surname>Kowalsky</surname><given-names>JR</given-names></name><name><surname>Ajw</surname><given-names>Te Velthuis</given-names></name><name><surname>Bloom</surname><given-names>JD</given-names></name></person-group><article-title>Single-cell virus sequencing of influenza infections that trigger innate immunity</article-title><source>J Virol</source><year>2019</year><volume>93</volume><pub-id pub-id-type="pmcid">PMC6600203</pub-id><pub-id pub-id-type="pmid">31068418</pub-id><pub-id pub-id-type="doi">10.1128/JVI.00500-19</pub-id></element-citation></ref><ref id="R66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drayman</surname><given-names>N</given-names></name><name><surname>Patel</surname><given-names>P</given-names></name><name><surname>Vistain</surname><given-names>L</given-names></name><name><surname>Tay</surname><given-names>S</given-names></name></person-group><article-title>HSV-1 single-cell analysis reveals the activation of anti-viral and developmental programs in distinct sub-populations</article-title><source>eLife</source><year>2019</year><volume>8</volume><elocation-id>e46339</elocation-id><pub-id pub-id-type="pmcid">PMC6570482</pub-id><pub-id pub-id-type="pmid">31090537</pub-id><pub-id pub-id-type="doi">10.7554/eLife.46339</pub-id></element-citation></ref><ref id="R67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hein</surname><given-names>MY</given-names></name><name><surname>Weissman</surname><given-names>JS</given-names></name></person-group><article-title>Functional single-cell genomics of human cytomegalovirus infection. 3</article-title><source>Nat Biotechnol</source><year>2022</year><volume>40</volume><fpage>391</fpage><lpage>401</lpage><pub-id pub-id-type="pmid">34697476</pub-id></element-citation></ref><ref id="R68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parker</surname><given-names>MD</given-names></name><name><surname>Lindsey</surname><given-names>BB</given-names></name><name><surname>Shah</surname><given-names>DR</given-names></name><name><surname>Hsu</surname><given-names>S</given-names></name><name><surname>Keeley</surname><given-names>AJ</given-names></name><name><surname>Partridge</surname><given-names>DG</given-names></name><name><surname>Leary</surname><given-names>S</given-names></name><name><surname>Cope</surname><given-names>A</given-names></name><name><surname>State</surname><given-names>A</given-names></name><name><surname>Johnson</surname><given-names>K</given-names></name><name><surname>Ali</surname><given-names>N</given-names></name><etal/></person-group><article-title>Altered Sub-Genomic RNA Expression in SARS-CoV-2 B.1.1.7 Infections</article-title><source>bioRxiv</source><year>2021</year><elocation-id>2021.03.02.433156</elocation-id></element-citation></ref><ref id="R69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zanini</surname><given-names>F</given-names></name><name><surname>Pu</surname><given-names>S-Y</given-names></name><name><surname>Bekerman</surname><given-names>E</given-names></name><name><surname>Einav</surname><given-names>S</given-names></name><name><surname>Quake</surname><given-names>SR</given-names></name></person-group><article-title>Single-cell transcriptional dynamics of flavivirus infection</article-title><source>eLife</source><year>2018</year><volume>7</volume><pub-id pub-id-type="pmcid">PMC5826272</pub-id><pub-id pub-id-type="pmid">29451494</pub-id><pub-id pub-id-type="doi">10.7554/eLife.32942</pub-id></element-citation></ref><ref id="R70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zanini</surname><given-names>F</given-names></name><name><surname>Robinson</surname><given-names>ML</given-names></name><name><surname>Croote</surname><given-names>D</given-names></name><name><surname>Sahoo</surname><given-names>MK</given-names></name><name><surname>Sanz</surname><given-names>AM</given-names></name><name><surname>Ortiz-Lasso</surname><given-names>E</given-names></name><name><surname>Albornoz</surname><given-names>LL</given-names></name><name><surname>Rosso</surname><given-names>F</given-names></name><name><surname>Montoya</surname><given-names>JG</given-names></name><name><surname>Goo</surname><given-names>L</given-names></name><name><surname>Pinsky</surname><given-names>BA</given-names></name><etal/></person-group><article-title>Virus-inclusive single-cell RNA sequencing reveals the molecular signature of progression to severe dengue</article-title><source>Proc Natl Acad Sci U S A</source><year>2018</year><volume>115</volume><fpage>E12363</fpage><lpage>E12369</lpage><pub-id pub-id-type="pmcid">PMC6310786</pub-id><pub-id pub-id-type="pmid">30530648</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1813819115</pub-id></element-citation></ref><ref id="R71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Neal</surname><given-names>JT</given-names></name><name><surname>Upadhyay</surname><given-names>AA</given-names></name><name><surname>Wolabaugh</surname><given-names>A</given-names></name><name><surname>Patel</surname><given-names>NB</given-names></name><name><surname>Bosinger</surname><given-names>SE</given-names></name><name><surname>Suthar</surname><given-names>MS</given-names></name></person-group><article-title>West nile virus-inclusive single-cell RNA sequencing reveals heterogeneity in the type I interferon response within single cells</article-title><source>J Virol</source><year>2019</year><volume>93</volume><pub-id pub-id-type="pmcid">PMC6401468</pub-id><pub-id pub-id-type="pmid">30626670</pub-id><pub-id pub-id-type="doi">10.1128/JVI.01778-18</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Figure 1</label><caption><p><bold>A</bold>. Illustration of SARS-CoV-2 genomic RNA, gRNA, and subgenomic RNAs, sgmRNAs. <bold>B</bold>. <italic>Top:</italic> Reads included for analysis by scCoVseq. Either: 1) contiguous reads mapping to ORF1a/b and therefore derived from gRNA or 2) discontinuous reads spanning the leader region and ORFS transcribed by sgmRNAs <italic>Bottom</italic>: Reads excluded from analysis by scCoVseq. Either: 1) discontinuous reads that do not include sequence mapping to the leader region or 2) contiguous reads that map to ORFs other than ORF1a/b, which are ambiguous. <bold>C</bold>. Activity diagram of scCoVseq pipeline. Blue rectangles indicate inputs/outputs for each stage. Orange rounded rectangles indicate a process in bold with software indicated.</p></caption><graphic xlink:href="EMS140197-f001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><p><bold>A-C</bold>. Illustration of gRNA and S and ORF3a sgmRNAs. Red box indicates regions contained in final 10X library. <italic>Lower:</italic> Example illustration of 10X library fragments derived from gRNA and S and ORF3a sgmRNAs with sequencing read 1 and read 2 indicated. 10X 3′ (<bold>A</bold>), 10X 5′ (<bold>B</bold>), and 10X 5′ extended R1 (<bold>C</bold>) libraries are illustrated. <bold>D-F</bold>. Sashimi plot of 10X 3′ (<bold>D</bold>), 10X 5′ (<bold>E</bold>), and 10X 5′ extended R1 (<bold>F</bold>) reads (Vero E6 cells) mapped to the SARS-CoV-2 genome filtered to show only junctions supported by at least 1,000 reads. Total number of reads visualized is indicated in the bottom right. <bold>G</bold>. Reads per million reads mapped to SARS-CoV-2 reads in 10X 3′, 10X 5′, or 10X 5′ with extended R1 data (Vero E6 cells). <bold>H</bold>. UMIs per cell for all sgmRNAs in infected cells in each dataset (Vero E6 cells). Each dataset was downsampled to an equal number of infected cells and each cells’ total UMIs were downsampled to the same value to control for differences in sequencing depth. The leader region is enlarged in illustrations of the genome for visibility. L = Leader.</p></caption><graphic xlink:href="EMS140197-f002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><p><bold>A-C</bold>. Correlation between viral sgmRNA quantification in bulk RNA-Seq by periscope and aggregated “pseudobulk” scRNA-Seq data of rSARS-CoV-2 ORF6 M58R infected ACE2-expressing A549 cells. The mean of three values for the fraction of total viral reads derived from each sgmRNA as quantified in bulk RNA-Seq are show on the x-axis. The fraction of total viral UMIs derived from each sgmRNA as quantified in scRNA-Seq are shown on the y-axis. Each point indicates a specific ORF. A regression line is fit to each graph, and Pearson’s correlation and resultant p values are shown for each analysis.</p></caption><graphic xlink:href="EMS140197-f003"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><p><bold>A</bold>. Viral gene expression in n = 3,047 mock and infected Vero E6 cells analyzed with 10X 5′ extended R1. Cells are embedded in tSNE space derived from Euclidean distance of scaled viral sgmRNA expression. <bold>B</bold>. Experimental condition and assigned infection status of cells, corresponding to tSNE in (A). <bold>C</bold>. Expression of viral genes in infected and uninfected Vero E6 cells. Cells are represented as columns with the expression of each viral gene indicated by color. Cells are ordered left to right by increasing total SARS-CoV-2 viral UMIs. Cells with total SARS-CoV-2 viral UMIs greater than the 99<sup>th</sup> percentile are “clipped” to the 99<sup>th</sup> percentile value for improved visibility. Cells are annotated above with assigned infection status. <bold>D</bold>. Correlation of viral gene expression across single cells as measured in 10X 3′, 10X 5′, and 10X 5′ extended R1.</p></caption><graphic xlink:href="EMS140197-f004"/></fig></floats-group></article>